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ABSTRACT OF DISSERTATION
Genetic Association Testing of Copy Number Variation
Copy-number variation (CNV) has been implicated in many complex diseases. It is of
great interest to detect and locate such regions through genetic association testings.
However, the association testings are complicated by the fact that CNVs usually span
multiple markers and thus such markers are correlated to each other. To overcome
the difficulty, it is desirable to pool information across the markers. In this thesis, we
propose a kernel-based method for aggregation of marker-level tests, in which first we
obtain a bunch of p-values through association tests for every marker and then the
association test involving CNV is based on the statistic of p-values combinations. In
addition, we explore several aspects of its implementation.
Since p-values among markers are correlated, it is complicated to obtain the null dis-
tribution of test statistics for kernel-base aggregation of marker-level tests. To solve
the problem, we develop two proper methods that are both demonstrated to preserve
the family-wise error rate of the test procedure -a permutation-based approach and
a correlation-base approach. Many implementation aspects of kernel-based method
are compared through the empirical power studies in a number of simulations con-
structed from real data involving a pharmacogenomic study of gemcitabine. In ad-
dition, more performance comparisons are shown between permutation-based and
correlation-based approach. We also apply those two approaches to the real data.
The main contribution of the dissertation is the development of marker-level asso-
ciation testing, a comparable and powerful approach to detect phenotype-associated
CNVs. Furthermore, the approach is extended to high dimension setting with high
efficiency.
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permutation, family-wise error rate
Author's signature: Yinglei Li
Date: November 7, 2014
iii
Genetic Association Testing of Copy Number Variation
By
Yinglei Li
Director of Dissertation:
Patrick Breheny and Dr.
Arnold Stromberg
Director of Graduate Studies: Dr. Constance Wood
Date: November 7, 2014
ACKNOWLEDGMENTS
First I would like to express my deep appreciations and gratitude to my advisors,
Dr. Patrick Breheny, for his time, detailed guidance, support and encouragement in
every step I made in my research. I greatly benefit from his profound knowledge and
scientific insight throughout my PhD study. I sincerely appreciate his instructions
and help in assisting me to finish my dissertation. Moreover, Dr. Patrick Breheny
helped to develop my research ability, scientific thinking, and analytical skills to a
great extent.
I would like to acknowledge my committee members: Dr. Arnold Stromberg, Dr.
Richard Charnigo, Dr. David Fardo, Dr. William Griffith for sharing their valuable
time and providing me helpful feedback of this dissertation. Your comments always
help me thinking more and digging more deeply about my research.
I am very grateful to my friends, Xiang Zhang, Jing Xi, and Shihong Zhu, for their
help provided during my dissertation research. Sincere thanks to all of my friends
who have made my life full of joy.
My appreciations also go to the Department of Statistics, which provided me with a
good environment to study and research.
I would like to thank my parents for your love, encourage, and belief in me; my
husband Tongfei, for your love, patience and support during my whole life. My final
and most heartfelt acknowledgement must go to my family. I greatly thank my par-
ents, my husband and my two sons for their endless love and supporting my decision
iii
to pursue the Ph.D. and work in research. You are always my constant source of
love, happiness, and strength all the years living in a country with a different culture
constituted. I made a big step forward and it is my pleasure to take this opportunity
to thank all the people contributing to it.
iv
TABLE OF CONTENTS
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
Table of Contents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
Chapter 1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Genetic background of Copy number variation . . . . . . . . . . . . . 1
1.2 CNV calling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.3 Marker-level testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.4 Outline of the dissertation . . . . . . . . . . . . . . . . . . . . . . . . 14
Chapter 2 Kernel-based Aggregation Method for Marker-level Association Test 15
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.2 Kernel-based aggregation of marker-level association tests . . . . . . . 18
2.2.1 Choice of kernel . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2.2 Transformation of p-values . . . . . . . . . . . . . . . . . . . . 22
2.2.3 Direction of association . . . . . . . . . . . . . . . . . . . . . . 23
2.2.4 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Chapter 3 Family Wise Error Rate Control for Permutation Method . . . . . 26
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3.2 Significance testing and FWER control . . . . . . . . . . . . . . . . . 28
3.2.1 Exchangeability . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.2.2 Permutation approach . . . . . . . . . . . . . . . . . . . . . . 31
3.3 Gemcitabine study . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.4 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.4.1 Spike-in data design . . . . . . . . . . . . . . . . . . . . . . . 38
3.4.2 Comparison of transformation . . . . . . . . . . . . . . . . . . 41
3.4.3 Comparison of kernel choice . . . . . . . . . . . . . . . . . . . 42
3.4.4 Comparison of kernel-based aggregation and variant-level testing 44
Chapter 4 Correlation Method and Its Family Wise Error Rate Control . . . 47
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
4.2 Basic idea about correlation method . . . . . . . . . . . . . . . . . . 48
4.2.1 Correlation approach . . . . . . . . . . . . . . . . . . . . . . . 48
4.2.2 Replacing correlation among z statistics with correlation of in-
tensities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
4.2.3 Estimate of correlation matrix of intensities among markers . 52
v
4.3 Extending correlation approach to small n, large J setting . . . . . 53
4.4 Extending correlation approach to large n, large J setting . . . . . . 59
4.4.1 Introduction to shrinkage approach . . . . . . . . . . . . . . . 64
4.4.2 Shrinkage estimation of sparse positive definite correlation matrix 66
4.4.3 Selection of the number of sparse diagonals and appropriate
shrinkage intensity . . . . . . . . . . . . . . . . . . . . . . . . 68
4.5 Simulation Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
4.5.1 Preservation of type one error . . . . . . . . . . . . . . . . . . 71
4.5.1.1 large n, small J setting . . . . . . . . . . . . . . . . 72
4.5.1.2 small n, large J setting . . . . . . . . . . . . . . . . 72
4.5.1.3 large n, large J setting . . . . . . . . . . . . . . . . 74
4.5.2 Evaluating the estimated null distribution . . . . . . . . . . . 77
4.5.3 Performance of correlation procedure . . . . . . . . . . . . . . 77
4.5.3.1 large J setting . . . . . . . . . . . . . . . . . . . . 79
4.5.3.2 small J setting . . . . . . . . . . . . . . . . . . . . 81
4.6 Gemcitabine study . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
Chapter 5 Summary and Discussion . . . . . . . . . . . . . . . . . . . . . . . 87
Appendices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
A.Proof of Theorem 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
B. Proof of Theorem 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
C. R code for Permutation Method . . . . . . . . . . . . . . . . . . . . . . 93
D. R code for Correlation Method . . . . . . . . . . . . . . . . . . . . . . . 105
Bibliography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
Vita . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
vi
LIST OF FIGURES
1.1 Illustration of marker-level testing. The − log10(p) values on each position
along the partial chromosome based on the marker-level tests. . . . . . . 13
3.1 Ability of Monte Carlo and Permutation approaches to maintain family-
wise error rate under the two null scenarios. The implementation of CBS
provided by DNAcopy does not return p-values (only whether they fall
above or below a cutoff), and thus could not be included in this plot. . . 31
3.2 Analysis of the gemcitabine data (Chromosome 3) using the proposed
kernel aggregation method. The kernel aggregations Tj are plotted against
chromosomal position. The red line indicates the cutoff for chromosome-
wide FWER significance at the α = .1 level. . . . . . . . . . . . . . . . . 38
3.3 Illustration of spike-in simulation design. Left: The noise, randomly drawn
from among the estimated measurement errors for a single cell line. Mid-
dle: The spiked-in signal. Right: The resulting simulated data. . . . . . . 40
3.4 Effect of transformation choice and direction of association on power. Pop-
ulation CNV frequency was set to 10%; optimal bandwidths used. . . . . 42
3.5 Effect of kernel choice on power. Left: Constant-width kernel vs. constant-
marker kernel. Right: Flat vs. Epanechnikov kernel. In both plots, pop-
ulation CNV frequency was 10%, test results were unsigned, and the log
transformation was used. . . . . . . . . . . . . . . . . . . . . . . . . . . 43
3.6 Power comparison of variant-level testing (using CBS for CNV calling)
with marker-level testing (using kernel-based aggregation). . . . . . . . . 45
4.1 This is the sample correlation matrix. Red values are high correlation; the
only legitimate correlations are located in the CNV. The rest is just noise. 61
4.2 This is sparse matrix with d = 30 on both sides. It has the same central
banded correlation with the rest correlations equal to zero. . . . . . . . . 62
4.3 It is also a sparse estimate of correlation matrix with d = 15 on each side.
The important part of the correlation was chopped off. . . . . . . . . . . 63
4.4 Effect of the number of sparse diagonals on optimal shrinkage intensity.
True CNV size is set be 50 and total number of markers is 500. . . . . . 69
4.5 Effect of the number of sparse diagonals on preservation of type one error
when choosing different bandwidth for kernel aggregation method on nor-
mal signed transformation. True CNV size is set be 50. The horizontal
red line is for α = 0.05 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
4.6 Ability of correlation approach under different transformations in signed
directions of association for Large n, small J setting to maintain family-
wise error rate under the two null scenarios. . . . . . . . . . . . . . . . . 73
4.7 Ability of SVD approach under small n, large J setting for different
transformations of p-values in signed association to maintain family-wise
error rate under the two null scenarios. . . . . . . . . . . . . . . . . . . . 75
vii
4.8 Ability of shrinkage approach under different transformations in signed
association to maintain family-wise error rate under the two null scenarios. 76
4.9 Comparison of null distribution through permutation and three correlation
methods under large n, small J setting. The simulated genomic region
contained 200 markers, 30 of which were spanned by a CNV with signal-
to-noise ratio of 2. Population CNV frequency was presented in 50% of
1000 samples. Signed, normal transformation with bandwidth bw = 20
was used for kernel-based method. . . . . . . . . . . . . . . . . . . . . . . 78
4.10 Comparison of null distribution through permutation and three correlation
methods under small n, large J setting. The simulated genomic region
contained 500 markers, 30 of which were spanned by a CNV with signal-
to-noise ratio of 2. Population CNV frequency was presented in 50% of
50 samples. Signed, normal transformation with bandwidth bw = 20 was
used for kernel-based method. . . . . . . . . . . . . . . . . . . . . . . . . 79
4.11 Comparison of null distribution through permutation and three correlation
methods under large n, large J setting. The simulated genomic region
contained 500 markers, 30 of which were spanned by a CNV with signal-
to-noise ratio of 2. Population CNV frequency was presented in 50% of
300 samples. Signed, normal transformation with bandwidth bw = 20 was
used for kernel-based method. . . . . . . . . . . . . . . . . . . . . . . . . 80
4.12 Comparison of computation time versus sample size between correlation
methods and permutation approach. We set total number of markers to
be 2000 and the total number of samples changes from 10 to 1910 by 100.
CNV size are 30 markers. . . . . . . . . . . . . . . . . . . . . . . . . . . 81
4.13 Comparison of computation time versus sample size among three kinds of
correlation approaches. We set total number of markers to be 2000 and
the total number of samples changes from 10 to 1910 by 100. CNV size
are 30 markers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
4.14 Comparison of computation time versus sample size between permutation
approach and correlation method for low dimension. We set total number
of markers to be 200 and the total number of samples changes from 10 to
1910 by 100. CNV size are 30 markers. . . . . . . . . . . . . . . . . . . 83
4.15 Analysis of the gemcitabine data (Chromosome 3) using the proposed
correlation method. The kernel aggregations Tj are plotted against chro-
mosomal position. The red line indicates the cutoff of SVD approach and
the blue line shows the cutoff of shrinkage approach for chromosome-wide
FWER significance at the α = .1 level. . . . . . . . . . . . . . . . . . . . 86
viii
LIST OF TABLES
3.1 Preservation of Type I error for three methods with nominal α = .05 in
two possible settings for which the null hypothesis holds. The simulated
genomic region contained 200 markers, 30 of which were spanned by a
CNV. The CNV was present in either 0% or 50% of the samples, depending
on the null hypothesis setting. A detailed description of the simulation
data is given in Section 3.4. . . . . . . . . . . . . . . . . . . . . . . . . . 30
4.1 Preservation of Type I error for correlation method in large n, small
J setting for different transformations in signed direction of association
with nominal α = .05 in two possible settings for which the null hypothesis
holds. The simulated genomic region contained 200 markers, 30 of which
were spanned by a CNV with signal-to-noise ratio of 2. The CNV was
present in either 0% or 50% of the 1000 samples, depending on the null
hypothesis setting. A detailed description of the simulation data is given
in Section 3.4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
4.2 Preservation of Type I error for correlation method in small n, large
J setting for different transformations and directions of association with
nominal α = .05 in two possible settings for which the null hypothesis
holds. The simulated genomic region contained 500 markers, 30 of which
were spanned by a CNV with signal-to-noise ratio of 2. The CNV was
present in either 0% or 50% of the 50 samples, depending on the null
hypothesis setting. A detailed description of the simulation data is given
in Section 3.4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
4.3 Preservation of Type I error for applying shrinkage approach on correlation
method for different transformations in signed association with nominal
α = .05 in two possible settings for which the null hypothesis holds. The
simulated genomic region contained 500 markers, 30 of which were spanned
by a CNV with signal-to-noise ratio of 2. The CNV was present in either
0% or 50% of the 300 samples, depending on the null hypothesis setting. 76
ix
Chapter 1 Introduction
1.1 Genetic background of Copy number variation
An allele is one of a number of alternative forms of the same gene or same genetic lo-
cus that is located at a specific position on a specific chromosome. Genetic variation
is the variation in alleles of genes and it occurs both within and among popula-
tions. It is brought about by mutation, a change in the chemical structure of a gene.
Due to the improved understanding of variation in human DNA and development of
high-resolution assays that capable of detecting small segmental genetic alteration,
different kinds of genetic variation have been detected. These variations present
in an unexpected amount of forms, including single-nucleotide polymorphism, small
insertion-deletion polymorphisms, variable numbers of repetitive sequences, and ge-
nomic structural variation. Initial genetic variation studies mostly concentrated on
single-nucleotide polymorphisms (SNP). A SNP is a DNA sequence variation that
occurs when a single nucleotide (A,T,C or G) in a DNA sequence differs between
individuals. It is a single base change in the DNA. SNPs are thought to be the most
common form of genetic variation. In 2001 it was discovered that there are at least es-
timated 10 million SNPs commonly occurring within the human population [1]. The
international HapMap Project has identified over 3.1 million SNPs across the human
genome that commonly exist in the individuals of African, Asian and European ances-
try. SNPs have been considered to be the main source of normal phenotypic variation
for decades. However, a study by Maher [2] demonstrates that most common single
nucleotide polymorphisms associated with complex diseases have small effect size and
explained only 2−15% of heritable variation. Increasingly researchers have attempted
to discover other type of variation that might account for the remaining fraction of
the heritable variation.
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Prior to the day of DNA sequencing, very few gene number changes could be
detected by a microscope. During the past several years, hundreds of new forms
of variation in repetitive regions of DNA have been identified. Two groups of re-
searchers published landmark findings of detection of copy number variation among
the genomes of healthy individuals [3, 4]. Subsequent studies using more developed
methods expanded the results and provided more evidence for the existence of such
variation over large portions of the human genome. The number of copies of a seg-
ment of DNA in the genome is referred to as the DNA copy number for that segment.
Normally, most individuals have two copies of a given genomic segment of DNA.
A different number of copies results when an individual goes through one or more
deletions or duplications of a segment. Therefore, by choosing a genome reference
sequence, which is considered to have a "normal" number of copies, any individuals
with an abnormal number of copies at the same genomic region are defined to possess
a CNV at that region.
Copy number variants are now known to be a prevalent form of genetic variation
and account for a substantial proportion of genetic variability in human populations.
CNVs are categorized in many ways. Some authors subclassify CNVs in terms of the
size and frequency. Traditionally, CNV is defined as one type of structural variant
in a segment of DNA that is 1 kb or larger [5]. By the improvement of detection
technology, shorter segments are able to be detected and now also considered. Some
publications defined it with minor allele frequency (MAF). In a recent study [6],
> 90% of CNVs involved copy-number polymorphism that occurs in more than 1%
of the given population and > 80% common CNPs with MAF > 5%. The remain-
ing 10% consists of rare CNVs. This indicates that a large portion of copy number
variation come from common polymorphisms. By comparing the human genome ref-
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erence sequence with another genome sequence using the fosmid paired-end sequence
approach, Tuzun identified 297 sites of potential structure variation between the two
sequences, including 139 insertions, 102 deletion, and 56 inversions. [7]. The number
of identified CNVs is now increasing dramatically as the detection technologies have
improved. To date, approximately 180,000 CNV have been reported in the Database
of Genomic Variants (DGV), which records information about identified copy number
events. We make no distinction in forms of size or frequency in this dissertation and
use the term CNV for all kinds of copy number variation.
More and more studies demonstrate the potentially greater role of CNVs than
single base-pair sequence variation. It was estimated that 12% of the genome could
be affected by CNV in comparison to 1 − 2% covered by single nucleotide polymor-
phisms (SNPs) [8]. Ridon et al. constructed a first-generation CNV map of the
human genome after studying 270 individuals. They identified a total of 1,447 copy
number variable regions covering 12% of genome in these population. Another re-
search team pointed out that there are approximately 12 CNVs per entire genome
on average [3, 4]. But these results were based on the small number of genomes and
limited resolution of previous detection methods. Sharp et al. revealed that 61% of
the variants identified had not been discovered before [9]. It seems that the number
of CNVs is underestimated. By 2006, it appears that 1237 CNVs covering an esti-
mated 143 Mb genomic sequence had been identified, which is a substantial source of
genomic variation except SNP [10]. Analysis of the complete DNA sequence from a
single individual reported that CNVs account for about 22% of all genetic variation
in the individual and 74% of the total DNA sequence variation [11]. It is reasonable
to conclude that CNV accounts for an appreciable amount of phenotypic variation.
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An increasing number of studies are investigating the impact of copy number vari-
ation on various phenotypes. The duplication of the Bar gene in Drosophila was one
of the earliest studies on association of CNV with a phenotype. The variation was
shown to cause the Bar eye phenotype, which will narrow the eye field of affected
flies [12]. Another popular example is the duplication of part or all of chromosome
21 has been discovered to be linked to Down syndrome. More evidence reveals that
changes in copy number play an important role in evolution. A study by Stefansson et
al. [13] identified a common inversion with frequency of 20% in Europeans that indi-
cates positive selection. They analyzed tens of thousands of samples and investigated
that the inversion carrier females have more children than noncarriers. Numerous
examples of relevance between CNVs and complex diseases were observed by Redon
et al. [14]. CNVs are also found to be associated with Prader-Willi and Angelman
syndromes. Sebat et al. discovered association between deletion variation and risk
of autism [15]. Walsh et al. reported the contribution to schizophrenia disease and
Zhang et al. presented the risk to bipolar disorder [16,17].
Copy number variants do not necessarily have a negative effect on health. A num-
ber of studies provided the evidence that some specific large duplication or deletion do
not apparently result in disease [1821]. In 2004, two groups independently detected
the widespread presence of CNVs among the genomes of healthy individuals. [3, 4].
By constructing a targeted bacterial artificial chromosome (BAC) microarray, 119
regions of CNVs were identified, with 73 unreported previously, on a panel of 47 nor-
mal individuals representing four different population. The study also demonstrated
that segmental duplications occur at hotspots of chromosome rearrangement, acting
as causes of normal variants as well as genetic disease [9].
4
1.2 CNV calling
It has became one of the compelling genetics challenges during the last few years
to understand the contribution of copy number variation to the phenotypes such as
disease state. As many CNVs are rare, it is difficult to conduct statistically signifi-
cant association between a single rare CNV and the disease status. Instead, several
studies examine the association between phenotype and total CNVs in the whole chro-
mosome. Through case-control testing, these studies identified associations between
copy number changes and various diseases, including autism, schizophrenia and bipo-
lar disorder [1517]. Previous studies of copy-number variation in human populations
have largely been restricted to hundreds of individuals and therefore were unable to
distinguish variants that are truly rare. More and more recent studies have begun to
expand to substantially larger sample size.
Genome-wide association studies (GWAS) in large samples of cases and controls
are commonplace and therefore an efficient approach is to carry out association stud-
ies involving CNVs using the same data. GWAS is an examination of genetic variation
across human genome. It tests markers across the complete sets of genomes of many
people to identify genetic association with clinical phenotypes. Researchers use two
groups of participants to conduct the study: people with the disease (case) and simi-
lar people without the disease (control). The entire genome, which contains millions
of genetic variants, is investigated through the case-control testing. If a certain vari-
ant is found to be significantly more frequent in people with disease, this type of
variation is said to be "associated" with the disease. The associated variant might
not directly cause the disease and is considered to be "tagging along" with the actual
casual variant. In a typical GWAS, genetic variants are read by SNP arrays, a more
popular and common type of DNA microarray data used to detect polymorphisms
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within a population. Hence, GWAS typically presents the associations between single-
nucleotide polymorphisms (SNPs) and the observed traits. GWAS was first applied in
2005 on patients with age-related macular degeneration(AMD) and two SNPs were
detected to influence the risk of disease by case-control testing. Such studies are
substantially useful and have already successfully identified hundreds of genetic vari-
ations contributing to common, complex diseases. GWA studies often require a large
number of samples in order to obtain a reliable signal of risk-SNPs. It was reported
by Ehret et al. [22] that the largest sample size was in the range of 200,000 individuals.
There have been several techniques proposed for measuring copy-number vari-
ation. Traditionally, large chromosome rearrangements have been detected with
G-banded karyotypic analyses or fluorescence in situ hybridization (FISH) using
fluorescent probes that bind to part of the chromosomes. With the development
of microarray technology, array-based comparative genomic hybridization (aCGH)
was one of the widely used techniques. This technology was first introduced as
"matrix-CGH" [23]. This technique involves labeling a reference genome and a test-
ing genome with different fluorescence markers, hybridizing to the microarray with
genomic clones, and then analyzing the intensity of the hybridization signal for each
clone. Then the array-CGH technique has been through a lot of improvements such as
BAC Array Comparative Genomic Hybridization, Representational Oligonucleotide
Microarray Analysis (ROMA) and Agilent CGH [24] to detect CNVs in human pop-
ulations.
The CNV studies were restricted to a list of selected candidate genes due to the
cost and complexity of CNV assessment. High-throughput single nucleotide poly-
morphism (SNP)-array technologies provide possibility to investigate copy number
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variants (CNVs) in genome-wide scans and specific calling algorithms have been de-
veloped to determine CNV location and copy number. High-density single nucleotide
polymorphism (SNP) genotyping arrays have recently become more popular for CNV
detection and analysis, because the arrays are available for both SNP-based and CNV-
based association studies. Furthermore, they provide considerably higher precision
and resolution than traditional techniques. Since vast amounts of these data have
been already generated during the pursuit of conducting genome-wide association
studies (GWAS) among SNPs, it has tremendous advantages and merits in terms of
convenience and low expense for studies. Hence it is expected to continue to be the
main approach for several years to come. However, there are limitations to using
SNP genotyping arrays for CNV detection. One obvious limitation is that SNPs are
not uniformly distributed across the genome and are sparse in regions with segmental
duplication or deletions [25]. The new-generation SNP arrays, such as the Infinium
Illumina Human 1Million probe chip and the Affymetrix 6.0 platform, have now in-
corporated additional nonpolymorphic (NP) markers to provide more comprehensive
coverage of the human genome and thus overcome this limitation. They are proven
to be a method for detecting CNVs and now are commonly used to obtain the copy-
number measurement recently. In my thesis, I focus here on detection of coy-number
variation using raw data from genome-wide single nucleotide polymorphism (SNP)
arrays.
In high-density SNP genotyping platforms, a signal intensity measure is sum-
marized for each allele of any SNP. Thus, each marker from SNP arrays consists
of two intensity measurements, corresponding to the A and B allele [26, 27]. First,
quantile-normalization is required for each probe intensity. After normalization of
both intensities, a polar coordinate transformation is applied, generating two param-
eters R and θ. R refers to the sum of normalized intensities for both alleles and θ
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is called as an allelic intensity ratio representing the relative allelic intensity ratio of
two alleles. The observed normalized intensity R from a subject is then compared to
the expected value of R given neutral copy number, which is computed from linear
interpolation of canonical genotype clusters (AA, AB and BB) obtained from a large
set of reference samples. Such comparison thus generates a R ratio. Finally, a log
transformation is applied to the R ratios. The result, which is called the log R ratio
(LRR), is reported along the whole genome for every single marker on the array.
LRR serves as a continuous measurement of copy number. A position or a region
with no CNV presenting should have LRR equal to zero. Higher LRR intensities are
signals of copy number gain at those positions in the test samples and similarly lower
LRRs indicate the copy number loss. Analysis of signal intensities across the genome
can then be used to identify regions with CNVs [26]. Because of the LRR noise, the
drop or increase in LRR might not be obvious. Therefore, it is necessary to apply
statistical methods to distinguish the signal from noise.
There are broadly two main estimation goals for CNV detection - inferring the
copy numbers and accurately locating the CNV boundaries. There have been numer-
ous publications proposing methods to segment a genome into various regions of con-
stant copy number, which is called "CNV calling". Some methods involve a penalized
likelihood to estimate the breakpoint(CGHseg), using an expectation-maximization-
based technique (ChARM) and building hierarchical clustering-style trees along each
chromosome (CLAC) [28,29]. Other papers introduce Bayesian method, the use of a
genetic local search algorithm (GA), a wavelet approach(Wavelet), and an extension
of the SW-ARRAY algorithm to identify potential breakpoints. Additional proposals
include Quantile Smoothing (Quantreg), adaptive weights smoothing (GLAD) and
analysis of copy errors (ACE). Hidden Markov model (HMM), circular binary seg-
mentation (CBS), and fused lasso are the most commonly applied techniques. We
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present here the description of circular binary segmentation.
First proposed by Olshen et al. [30], circular binary segmentation (CBS) is a
non-parametric modified change-point method. As CNVs often extend over multiple
markers, it is more resonable to focus on a whole chromosome combining information
from neighboring markers than analysis on single one marker at a time. By con-
necting the two ends of each chromosome, the method offers a nice way to split the
chromosome into contiguous regions of constant copy number and model into discrete
copy number gains and losses at the same time. Bypassing parametric modeling of
the data, it uses a permutation reference distribution to assess the significance of
the proposed splits. The selection process, which recursively splits each contiguous
segment, is performed until there is no more significant splits among chromosome.
Lai et al. reported that CBS performs consistently well compared to other 10 ap-
proaches [29].
The main idea behind circular binary segmentation(CBS) is summarized as fol-
lows. It uses log R ratios (LRR) as input data and analyzes on each chromosome of
a single individual,
1. Joining the first and the last marker of the chromosome, the sequence of LRR
intensities become circular.
2. For every potential way of splitting the circle into complimentary arcs, compute
the two-sample t-statistics to compare the means between two arcs
3. Segment the circle somewhere that the maximum of test statistics exceeds the
critical value
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4. Repeat 2-3 steps recursively for testing the change-points until no additional
significant segment can be found
The details of the procedure are presented in these two papers [30,31]. The R package
DNAcopy is used to conduct the analysis. It is a package of the Bioconductor project
and is available at http://www.bioconductor.org/packages/release/bioc/html/DNAcopy.html.
It provides the estimates of the mean LRR at every marker among the given genome
for output. Those estimates are constant over each arc and therefore give an estima-
tion of the CNV structure. DNAcopy is considered to be one of the best operational
algorithm in terms of its sensitivity and FDR criterion for breakpoint detection [28].
Unfortunately, DNAcopy is also one of the slowest algorithms [29].
A number of articles [28, 29, 3234] have compared numerous methods or algo-
rithms that are adapted for CNV calling. There are no best or optimal algorithm so
far. Each algorithm uses different strategy for CNV calling and thus there are ob-
vious variabilities among calling algorithms. The emerging algorithms have different
assumptions for CNV detection. In other word, different CNV calling algorithm pro-
vides substantially different quantity and quality of CNV calls even for identical raw
data. Therefore, the choice of analysis tools is very important for CNV association
studies. Some authors have advised using multiple algorithms on the same data to
minimize the false discoveries and thus merging call sets from those algorithms could
improve sensitivity [33]. Careful normalization of the intensity is required because
hybridization signals are very sensitive to experimental noise that might result in even
opposite inference. Furthermore, the accurate CNV detection depends on the choice
of the array data. Pinto et al. pointed out that some methods are developed specifi-
cally for a certain array data and thus perform always better than other algorithms
only in such array data [33]. Additionally, many algorithms developed generally per-
10
form well for identifying large CNVs. Attempting to localize small CNVs even with
only one single probe, it results in many false positives. In conclusion, efforts are
ongoing to improve methods for CNV calling at the genome-wide level and test for
association in large samples of cases and controls.
1.3 Marker-level testing
Two general strategies have been proposed for conducting genetic association studies
of copy-number variation. The first approach, which we refer to as variant-level test-
ing, is to do "CNV calling" at the level of each individual first and then carry out
association tests of whether individuals with a CNV differ from individuals without
a CNV with respect to some phenotype. It is the more popular strategy for testing
CNV associations. However, the result of this test mainly depends on the detection of
CNV regions in the first step. Moreover, it is still challenging to separate each genome
into regions of constant copy number as discussed in last section. Furthermore, there
are additional complications for the variant-level approach. One of the big issues is
partially overlapping CNVs. Since CNVs are detected person by person, CNVs do not
necessarily share the same boundaries. When the sample size gets large, the num-
ber of overlapping patterns may be considerable. Whether those represent the same
CNV or different CNVs can be a complicated decision. Also, because CNVs do not
overlap perfectly among individuals, the association tests are correlated, leading to
problems when doing multiple testing. Moreover, it effects the association test when
using different threshold to declare a CNV present. If the threshold is too high, true
CNVs might be undetected; if the threshold is too low, neutral regions would be de-
fined as CNVs and thus create misclassification and lower power of association testing.
11
The alternative approach called "Marker-level testing", is also a two-stage pro-
cedure, which reverses the order of variant-level testing. Since variant-level testing
presents a number of difficulties, marker-level testing becomes an attractive alterna-
tive. In the first stage of marker-level testing, we carry out association testing at
the level of the single marker between raw intensity measurements and phenotype of
the null hypotheses "H0i: the ith marker is not associated with the ith phenotype".
Here intensity is a continuous measurement of copy number at every genetic marker.
Furthermore, we could get the association test results using a linear regression model
if the phenotype is also a continuous variable. Note that we do not involve specific
CNV calling in this step and thus we do not have to deal with difficulties from "CNV
calling". The key point here is that, because the data is noisy, it is virtually impos-
sible to identify CNV associations from a single marker. Since copy number variants
span over multiple markers in a sufficiently high-density array, the presence of a sin-
gle CNV that affects the phenotype will elevate the test statistics for several nearby
markers. This is the motivation for the second stage of marker-level testing. To carry
out inferences regarding CNVs by pooling test results across neighboring markers to
determine CNV regions associated with the phenotype is the main job of stage II. By
conducting a multi-locus association test along the chromosome, combining neighbor-
ing p-values, we can detect a region for copy number-phenotype association with low
p-values in close proximity to each other marker. It requires a systematic method for
pooling information across the neighboring hypothesis tests to identify the regions
in which low p-values are aggregated. In the dissertation, I develop a kernel based
approach on p-values to identify CNVs associated with a phenotype by aggregating
p-values and show it has a well-controlled false positive rate and high power.
The negative log transformation of the p-values are shown in Figure 1.1 for every
marker along a part of chromosome. The p-values are the results from the first step
12
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
ll
l
l
l
l
l
l
l
ll
ll
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
ll
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
ll
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
102.2 102.4 102.6 102.8 103.0
0.
0
0.
5
1.
0
1.
5
2.
0
2.
5
3.
0
Position (Mb)
−
lo
g 1
0(p
)
Figure 1.1: Illustration of marker-level testing. The − log10(p) values on each posi-
tion along the partial chromosome based on the marker-level tests.
of marker-level testing, which test associations between copy number intensity and
phenotype at every marker. From the plot, we spot the cluster of small p-values be-
tween 102.5 and 102.7 Mb. This region with so many low p-values in close proximity
to one another suggests an association between the phenotype and the copy num-
ber variation. In addition, marker-level testing, the main idea of which is illustrated
in the figure, avoids the complications of overlapping problems in variant-level testing.
Both of the above statistical technologies consist of two stages. This might result
in power loss in the second stage since those approaches risk losing information in the
the first stage. The type of information lost by each approach is different and hence
it is strongly implicated for the power comparing between those two approaches. A
recent paper by Breheny et al., in which CBS was used for segmentation in both
approaches, demonstrates that variant-level testing has greater power to detect as-
sociation involving large, rare CNVs while marker-level testing has more power to
detect small, common CNVs [35].
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1.4 Outline of the dissertation
The remainder of this thesis is organized as follows. In Chapter 2, a kernel-based
aggregation of marker-level association test is developed in detail. Since p-values
between markers are correlated with each other, the exact distribution becomes com-
plicated. In the following 2 chapters, two different computational approaches are
proposed to overcome the difficulty. I introduce a permutation procedure in chapter
3 and correlation method in chapter 4. In these two chapters, I also illustrate the
preservation of type one error and apply both approaches to both simulated and real
data. Finally, I summarize the results and discuss future directions in Chapter 5.
Copyright© Yinglei Li, 2014.
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Chapter 2 Kernel-based Aggregation Method for Marker-level
Association Test
2.1 Introduction
Recent advances in genome, such as the completion of human genome sequence and
rapid improvements in SNP genotyping technology, have accelerated the process of
locating candidate genes. The development of statistical and computational strate-
gies on hundreds of loci have investigated relationships between genome variation
and phenotypic variation. In spite of such advances, no comprehensive, well-powered
approach has been published to identify genes and loci that contribute to common dis-
ease. It has been receiving considerable attention to detect and locate CNV markers
over the past several years. Association test is broadly considered and highly accurate
to identify disease susceptibility genes related to complex disorder [36]. The choice of
association test is one of the main and important factors for a successful association
study. Before the emergence of large-scale association studies, many study of human
genetics has suffered from the problem of inadequate statistical power, which results
in low rates of successful replication among reported significant associations. It is
always worthwhile to choose a good statistical method to maximize the statistical
power and preserve well-controlled false positive rate.
Genome-wide association studies (GWASs) were made feasible in the late 2000s.
Because of the enormous size of the data sets, GWASs have tended to use simple
statistical procedures for one gene at a time throughout the genome. This single-
locus testing detects one gene at a time and is more suitable to study a susceptibility
gene with strong main effect on complex disorders. Evaluating one gene at a time
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focuses on its marginal effect on disease. Of course, there is no problem if focusing on
only one particular hypothesis. The marginal or individual p-values does not incor-
porate any information about the dependence structure between these p-values. As
many genes are being tested simultaneously, keeping the significance threshold at the
conventional value of 0.05 would lead to a large number of false positive significant
results. Such classic nominal significance-threshold framework is inappropriate for
such studies. For example, if α = 0.05 is the nominal significance rate for one marker
and n = 100 independent markers are tested at the same time, then false-positive
results will be obtained at a frequency of 1 − (1 − α)n = 0.99. It means that there
is a chance of greater than 99% that one or more markers are shown to be signif-
icantly related to disease. This is obviously an unacceptable rate. Such problem
involving multiple testing and its effect on the genomewide type I error is the subject
of a ongoing debate [37]. There have been proponents for an alternative approach
to multiple testing adjustments. The traditional and the most widely used method
is standard Bonferroni correction. The Bonferroni correction sets the critical signifi-
cance threshold at α divided by the number of tests. For example, with 20 tests and
α = 0.05, you'd only reject a null hypothesis if the p-value is less than 0.0025. The
Bonferroni correction tends to be a bit too conservative. We calculate the probability
of observing at least one significant result to be 0.0488 when assuming that all tests
are independent of each other. In practical applications, that is often not the case.
Depending on the correlation structure of the tests, the Bonferroni correction could
be extremely conservative, leading to a high rate of false negatives.
Identifying regions of genome or candidate genes that are correlated to contribute to
disease is difficulty because complex traits presumably arise from multiple interacting
genes with rather small effect. As there are many susceptibility loci, each single gene
will have only a small effect and cannot easily be detected by single-locus method.
Therefore, it would be appropriate to consider and analyze sets of marker loci jointly
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for genomewide association analysis rather than marker-by-marker approach that
completely ignores the possible interactions between susceptibility genes. In recent
years, multi-locus method is widely used for association study to localize the disease-
related genes [38] since a high density of markers and high-resolution microsatellite
maps are available. Investigating association between marker genotypes and disease
phenotypes for multiple markers will capture more information regarding the total
combined effects of all disease genes and therefore increase the statistical power for
disease gene detection compared to single-locus inference that analysing one locus at
a time. Researchers have developed different kinds of multi-locus association analy-
sis. For instance, there are multi-factor dimensonality reduction (MDR) by Ritchie
et al. [39], statistic combination tests by Hoh et al. [38] and p-value combinations by
Zaykin et al. [4042].
Our research focuses on the p-value combination methods. p-value combination
began with Fisher's product p-value method or the sum of log scale of p-values
(PPM) [43]. Later, other p-value combination methods such as the sum p-value
method(SPM) [44] and the minimum p-value method (MPM) [45] were developed.
Then p-value truncation was introduced by Wilkinson [46] and extended into trun-
cated product p-value method [40] and recently the rank truncated product p-value
method [41, 47]. There is no uniformly most powerful method of combining p-
values [40]. In this thesis, I am aimed to develop a new and modified p-value combi-
nation method for powerful multi-locus association scans and apply it to large-scale
simulation studies and real data analysis.
17
2.2 Kernel-based aggregation of marker-level association tests
I introduce a two-stage procedure for an association study to locate disease suscepti-
bility CNVs related to complex traits. Let n denote the sample size and J denote the
total number of markers. Consider a study region that contains J markers at different
positions. Here I use i to index subjects and j to index markers with positions `j used
to denote the location of marker j along the chromosome. Suppose our analysis data
consist of a set of marker genotypes together with phenotypic trait values measured
on each individual (X i, yi), i = 1, 2, ...n, where X i = (Xi1, ..., XiJ)T are the copy
number intensity of every marker for subject i and yi is the phenotype for subject i.
Here Xij represents the intensity measurement for subject i at marker j. In the first
stage, we conduct J association tests for every single locus under the null hypothe-
sises H0j: the jth marker is not associated to the phenotype, j = 1, ..., J . I refer to
the location at which a test statistic is computed as an analysis point. Then a series
of p-values are calculated from the association test between intensity and phenotype
for every marker. The association from the single-locus tests is the marginal effect of
each locus in the genome ignoring inter-marker association. The key to detect CNV
is the detection of significant association between phenotypic trait values and the
markers or intervals in a genetic map, which leads to the second stage.
In the second stage, a multi-locus association test combining multiple neighboring
p-values is performed. Compared to single-locus tests, multi-locus tests may increase
testing power by including the combined effect of disease-associated loci and inter-
marker relationship. Consider a window with multiple markers. Define the the central
marker as anchor locus, which is denoted as `0. The anchor marker is used to capture
disease genes. Let h denote bandwidth and construct a window by simultaneously
considering h before and after the anchor. I apply a kernel-weighted moving average
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for each window across our study region. Sliding windows formed scanning the entire
study region. Scanning all loci from the starting marker to the end marker, the whole
study region will be divided into overlapping windows as we shift the anchor locus.
Within each window, consider the local average for anchor `0, the center of a window.
T (`0) =
∑
j tjKh(`j, `0)∑
jKh(`j, `0)
, (2.1)
where tj = f(pj) is a function of the p-value for marker j. The smoothing parameter
h, which defines the bandwidth of the kernel, controls the size of the neighborhood
around the center location `0. Every marker within the window may contribute to
the identification of disease genes, and the extent of each marker contribution is con-
sidered by assigning proper weights to markers within a window. The kernel function
K controls the weight given to every pj in the neighborhood based on how far away
marker j is along the chromosome from the target location `0. The higher weights are
assigned to the markers closer to the anchor and lower effects for remote marker loci.
The smoothing parameter h meanwhile effects the bias-variance tradeoff. A larger
bandwidth will decrease variance by pooling p-values among a boarder region but in-
troduce more bias because considering more extra test results beyond the boundary
of a CNV.
One could apply (2.1) at any arbitrary location `0. We restrict our consideration
to a finite set of aggregations {Tj} from reasonable locations at which a marker is
present and the bandwidth does not exceed the borders of chromosome. Furthermore,
the transformation of p-values is chosen such that low p-values produce large values
of tj, leading to significance testing based on the statistic T = maxj{Tj}.
In this section, we describe in detail the choice of kernel Kh and transformation
f(pj), as well as the issue of the direction of association for signed tests.
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2.2.1 Choice of kernel
In nonparametric analysis, the goal is to smooth the data in some way and estimate
a curve. Kernel-based approaches are an important class of smoothing methods. The
main idea behind the method is to assign location weight based on each observation
and then aggregate them to yield an overall local average. Additional details of this
method and its application to CNV association studies will be discussed here.
There are usually two primary choices with regard to the kernel: kernel function
and bandwidth selection. First, let's consider the shape of the kernel. Consider two
frequently used kernel density functions, flat (boxcar) kernel and the Epanechnikov
kernel, are considered in our study:
Flat(boxcar) : Kh(`j, `0) =

1 if |`j − `0| ≤ h
0 otherwise
(2.2)
Epanechnikov : Kh(`j, `0) =

3
4
{
1−
(
`j−`0
h
)2}
if |`j − `0| ≤ h
0 otherwise
(2.3)
The Epanechnikov kernel would seem to be more attractive, as it gives higher
weight to markers close to the anchor location, and negligible weight to remote mark-
ers where bias is a larger concern.
Besides varying the shape of kernel, the quality of the kernel estimate depends
more on the definition of its bandwidth. Since the aggregation function (2.1) con-
siders the weighted average of a few markers within the bandwidth of the center
marker, it would be interesting to consider two definitions of bandwidth, which we
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refer to as constant width and constant marker (these concepts are named metric
and adaptive bandwidths, respectively, in kernel smoothing literature). In the con-
stant width approach, the width h of the kernel is constant in functions (2.2)-(2.3).
Meanwhile the number of markers for every kernel window varies the target location
`0 changes, thereby suffering from fluctuating variance. In contrast, the constant
marker approach provides constant number of markers for each kernel window. But
meanwhile it produces various range of the kernel, thereby suffering from bias. Specif-
ically, hk(`0) = |`0− `[k]|, where `[k] is the location of the kth closest marker to target
location `0. Simulation results regarding the benefits and drawbacks of these various
kernels are shown in the next chapter.
As a matter of reference, the flat, constant marker kernel is similar to the simple
moving average, although not exactly the same. The boxcar kernel for constant
marker method assigns the same weight of 1 to the effective markers which are within
the h nearest neighbors to `0 and assigns 0 otherwise. For example, consider the
following illustration.
l l l l l l
1 2 3 4 5 6
Suppose h = 3. We keep varying the target location, `0 to get the aggregation for
each marker. Unlike the moving average, constant marker kernel looks for the nearest
neighborhood to the target location. For example, at `3, the three nearest neighbors
are {p1, p2, p3}, while at `4, the three nearest neighbors are {p4, p5, p6}. Thus, combi-
nations such as {p3, p4, p5} are not considered by the kernel approach. One obvious
benefit of this method is to exclude the aggregation over inappropriately disperse
regions of the chromosome.
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2.2.2 Transformation of p-values
As suggested in (2.1), directly pooling p-values is not necessarily optimal. We consider
various transformations of p-values in a way that low p-values lead to high values
of tj = f(pj) and hence the statistic T = maxj{Tj} of association testing. Such
transformations might better discriminate true association from noise. Three main
transformations, uniform, Gaussian, and logarithmic, are considered as follows:
p : tj = 1− pj (2.4)
Z : tj = Φ−1(1− pj) (2.5)
log : tj = − log pj, (2.6)
where the text to the left of the equation is the label with which we will refer to these
transformations in later figures and tables.
As mentioned in Section 2.1, all these three transformations have a long history
in the field of combining p-values methods. Ronald Fisher first proposed the Fisher
combination test, which is based on the the average of log p values or equivalently, the
log of the product of the p-values [48]. An alternative procedure developed by Samuel
Stouffer [49] depends on the sums of normal-transformed p-values Zi = Φ−1(1− pi).
Finally, (2.4) was studied and derived by Edgington [44]. Several other researchers
have followed upon and developed these methods [5053]. Throughout this thesis, the
majority of work will focus on these thee scales uniform, Gaussian, and logarithmic.
Each of these methods has its respective advantages and has proven practical and
valuable in different fields. There is no uniformly most powerful method of combining
p-values [40]. Comparisons of the uniform, Gaussian, and logarithmic transformations
by simulation are shown in the later chapter.
22
In the p-value combination literatures, tests were assumed to be independent for
the convenience of theoretical development. However, this assumption is too strin-
gent for many practical application. If p-values within a window are statistically
dependent, a problem common to all of these methods is the difficulty of determining
or approximating the distribution of test statistic under an appropriate null hypothe-
sis. More recently, different computational algorithms have been proposed to generate
null distribution with dependent p-values, such as permutation, bootstrap, and Monte
Carlo [54].
Moreover, since marker-level testing does association tests for every marker among
the chromosome first and then locates the CNV, the borders of the CNVs are un-
known, as is the appropriate set of p-values to combine. Consequently, we must
calculate many different combinations {Tj}, which yield partially overlapping sets
and contain p-values of the same markers in different combinations. Clearly, the
resulting test statistics {Tj} will not be independent. This is a concern that must
be addressed for further studies. The implications of such concerns are addressed in
chapter 3 and 4.
2.2.3 Direction of association
In (2.1), the association test between intensity and phenotype at each marker, is un-
restricted and could arise from any kind of association test. Some association tests
such as z tests and t tests have a direction associated with them, while others such as
χ2 tests and F tests do not. If the direction is available along with the test, it is ad-
vantageous and valuable to incorporate this direction into the analysis of multi-locus
association tests as we will see in Section 3.4.
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Let sj denote the direction of association at marker j. For example, in a case con-
trol study, if intensities are higher for cases than controls at marker j, then sj = 1.
Otherwise, at markers where CNV intensities are higher for controls than cases,
sj = −1. The signs are arbitrary; their purpose is to reflect the fact that switch-
ing directions of association are inconsistent with the biological mechanism being
studied  an underlying, latent CNV that affects both phenotype and intensity mea-
sures  and thus likely to be noise. Considering this direction should diminish noise
and thus improve CNV detection. I introduce here extensions of the transformations
presented in Section 2.2.2 that include the direction of association.
When sj is available, I adjust the three transformations from 2.2.2 as follows:
p : tj = sj(1− pj) (2.7)
Z : tj = Φ−1
(
1 + sj(1− pj)
2
)
(2.8)
log : tj = −sj log pj. (2.9)
All of these transformations have the same effect as mentioned in Section 2.2.2: when
pj ≈ 0 and sj = 1, tj  0; when pj ≈ 0 and sj = −1, tj  0; and when pj ≈ 1,
tj ≈ 0 regardless of the value of sj. In other words, all the test results combine to
give an aggregate value T (`0) that is large in absolute value only if the test results
have low p-values and are consistently in the same direction.
2.2.4 Summary
The kernel-based aggregation method described above provides a nice way to test for
CNVs associated with the phenotype. First, we obtain a list of p-values for every
marker through multiple hypothesis tests. Then we combine and transform p-values
to yield a finite set of aggregations {Tj}. The final significance testing is based on the
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statistic T = maxj{Tj}. Here as described above, different choices of kernel, transfor-
mations of p-values and the direction of association test will effect the statistic and
thus effect the test power. The power comparisons through different choice will be
presented in the later chapter through simulation.
To determine the significance of maxj{Tj}, we must estimate its null distribution.
Since the p-values are not independent among markers, the estimate of the exact null
distribution gets complicated. In chapter 3 and 4, we propose two approaches  one
based on a permutation approach and the other based on estimating the correlation
structure directly  to give an estimate of the null distribution. Moreover, we apply
these approaches to the simulated and real data.
Copyright© Yinglei Li, 2014.
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Chapter 3 Family Wise Error Rate Control for Permutation Method
3.1 Introduction
In genomics, especially genetic association studies, it is common for tens of thousands
of genes or genetic markers to be measured. For our marker-level association testing,
the first step involves a large number of markers being testing simultaneously. As
discussed in Section 2.1, multiple hypothesis testing is a common problem in such
genomewide association studies. If one does not take the multiplicity of tests into
account, then the probability that some of the true null hypotheses are rejected by
chance alone may be unexpectedly large. In our studies, it is of great interest to
determine the phenotype-associated CNV region that spans several markers in the
second step. And we consider the test statistic containing a list of p-values in a
window for significant result. Thus such problem involving multiple testing arises
and should be considered and paid more attention since the decision is based on the
dependent structure of corresponding marginal p-values.
Failure to consider the effects of multiple comparisons would result in an abun-
dance of false positive results. To deal with the multiple testing problem, we must
extend the idea of type I error to acknowledge multiple testing. The traditional or
classical criterion for error control is the familywise error rate(FWER), which is de-
fined as the probability of rejecting one or more true null hypothesis. A procedure is
said to control FWER in the strong sense if FWER control at level α (FWER ≤ α
) regardless of which subset of hypotheses is true. Similarly, if the FWER control at
level α only when all null hypothesis are true, it is defined to control FWER in the
weak sense. We are then 1 − α confident that there are no false discoveries among
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the rejected hypothesis. Another alternative criterion for error control is the false
discovery rate(FDR), which is the expected proportion of falsely rejected hypotheses.
It was first introduced by Benjamini and Hochberg when proposing a step-down pro-
cedure to control FDR for independent structures [55]. It was later shown that this
procedure also controls FDR for certain dependence structures [56]. FDR is equal to
FWER when all null hypotheses are true. When the vast majority of the null hy-
potheses are true, as the case in association studies, it is common to focus on FWER
for the sake of simplicity. However, it would more appealing to use FDR in situations
where there are a large number of false null hypotheses involved [57].
With a high density of markers, our test statistics as described are highly corre-
lated for multiple testing. The assumption of independence among tests is strongly
violated. Many different computational approaches have been developed to overcome
this difficulty. One alternative approach is permutation testing approach [45, 58].
Permutation tests shue the phenotype values among subjects a number of times
and keep the order of genotype set to create permuted data sets that have ran-
dom genotype-phenotype associations. Monte Carlo procedure was proposed by
Zaykin [40] and a direct simulation approach was advised by Seaman and Müller-
Myhsok [59]. Permutation resampling procedure was considered in this chapter since
it is traditional and popular. The empirical joint distribution of the test statistics
using such permuted data serves as the reference null distribution to determine the
CNV-phenotype association.
In this chapter, I will describe the permutation method, which is applied to our
kernel-based aggregation of marker-level test. Then I will illustrate that this approach
controls FWER through simulation and proof. Applying such method through sim-
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ulation, I compare many aspects of the kernel-based aggregation association test
statistic.
3.2 Significance testing and FWER control
3.2.1 Exchangeability
In any analysis that involves aggregating marker-level test results, we must be able
to detect and quantify the significance of regions like those depicted in Figure 1.1.
This is not trivial, however. As we described in Section 2.2.2, The fact that p-values
among markers within a window are statistically dependent greatly increases the dif-
ficulty of estimating the exact null distribution. Thus this dependence introduces a
lack of exchangeability between test results, which complicates matters and causes
various naïve approaches to fail. In this section, I compare three approaches that I
tried during my research and illustrate the consequences of non-exchangeability in
testing the significance of a region with a preponderance of low p-values.
One approach, suggested in [35], is to use circular binary segmentation (CBS; im-
plemented in the R package DNAcopy). This method aggregates neighboring p-values
by calculating the two sample t-test statistic comparing the mean intensity of a given
region with that of the surrounding region. The significance of this test statistic is
quantified by comparing it to the distribution of maximum test statistics obtained by
permuting the {pj} values [30, 31]. However, the main assumption of this approach
is that the test results {pj} are exchangeable which is the justification for permuting
them.
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Alternatively, we may use the kernel-based method described in Section 2.2.1 to
aggregate the neighboring test results, thereby obtaining Tmax = maxj{Tj}. One
possible approach to generate the null distribution of Tmax is to rely on Monte Carlo
integration based on the fact that, under the null hypothesis of no association, all
p-values follow a uniform distribution. Thus, for any choice of transformation and
kernel in (2.1), we may generate an arbitrary number of {Tj} under the null and
then yield independent draws {T (b)max}Bb=1 from the null distribution function F0 of
Tmax. Then the estimate Fˆ0 is obtained using the empirical CDF of those draws
{T (b)max}Bb=1. Through this approach, we apply a test for the significant presence of a
CNV-phenotype association through the calculation of p = 1− Fˆ0(Tmax). The crucial
assumption here is that, under the null, the p-values among markers are independent
and so are {Tj}.
An alternative to generate the null distribution and quantify the significance of
Tmax is the permutation approach that is proposed and described fully in Section 3.2.2.
By permuting the phenotype prior to aggregation of the marker-level tests, it creates
the independence between intensity and phenotype among markers for each permut-
ing. Thus, using the empirical CDF of an arbitrary number draws {T (b)max}Bb=1, we
would obtain the estimate Fˆ0(Tmax).
Consider a genomic region in which individuals may have a CNV. The purpose of
the analysis is to detect and locate such a CNV if it is associated with a particular
phenotype. Thus, the null hypothesis for our association test may hold in one of two
ways: (1, No CNV) no individuals with CNVs in that region are present in the sam-
ple, or (2, No association) individuals with CNVs are present in the sample, but the
CNV does not affect the disease and thus dose not change the probability of develop-
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ing the phenotype. The preservations of type I error of the three methods discussed
above under each type of null hypothesis is shown in Table 3.1. It demonstrates that
while all three methods have the proper type I error rate in the `No CNV setting,
only the permutation approach preserves the correct type I error in the case where a
CNV is present, but not associated with the disease (No association). It's easy to see
that p-values are independent for all methods under null hypothesis 1 (No CNV).
When a CNV is present but not related to the disease for null hypothesis 2 (No
association), it is still true that the marginal distribution of each pj is Uniform(0,1)
for each marker. This phenomenon is also illustrated graphically in Figure 3.1.
Table 3.1: Preservation of Type I error for three methods with nominal α = .05
in two possible settings for which the null hypothesis holds. The simulated genomic
region contained 200 markers, 30 of which were spanned by a CNV. The CNV was
present in either 0% or 50% of the samples, depending on the null hypothesis setting.
A detailed description of the simulation data is given in Section 3.4.
Circular Kernel Kernel
binary Monte Permutation
segmentationCarlo
No CNV 0.05 0.06 0.06
No Association 0.20 0.54 0.06
Table 3.1 and Figure 3.1 demonstrate that CBS and kernel Monte Carlo are not
guaranteed to preserve the type I error in all settings. Exchangeability is very crucial
to be considered when estimating the null distribution. I also make the following
additional observations from comparison results: (1) The CBS approach is somewhat
more robust to the exchangeability issue than the Monte Carlo approach; i.e., its
type I error rate is not as badly violated. (2) The data simulated here for the no
association setting are a little bit exaggerated: the CNV was present in 50% of the
population and the signal to noise ratio was about twice as high as that typically
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No CNV
Monte Carlo
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
Monte Carlo
p
0.0 0.2 0.4 0.6 0.8 1.0
No CNV
Permutation
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
Permutation
p
0.0 0.2 0.4 0.6 0.8 1.0
Figure 3.1: Ability of Monte Carlo and Permutation approaches to maintain family-
wise error rate under the two null scenarios. The implementation of CBS provided
by DNAcopy does not return p-values (only whether they fall above or below a cutoff),
and thus could not be included in this plot.
observed in real data. In more realistic settings, the violation of type I error rate
will be not nearly as severe. (3) Circular binary segmentation was developed for the
purpose of detecting CNVs, not aggregating marker-level tests, and thus its failure to
preserve the family-wise error rate in this setting is in no way a criticism of CBS in
general.
3.2.2 Permutation approach
The concept of permutation tests was first proposed by Fisher(1935). Good(1994)
provided an introduction to the theory of permutation testing. A summary of the
theory of permutation tests can be found in Lehmann (1986). Permutation tests are a
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class of widely-applicable non-parametric tests. They use random shues of the data
to estimate the correct distribution of a test statistic under a null hypothesis. They
provide valid tests with the advertised Type I error, although they are more com-
putationally intensive than standard statistical tests. Permutation tests are widely
used in genetics and genomics. They are especially useful when we have insufficient
information about the distribution of the data, are uncomfortable making assump-
tions about the distribution, or if the distribution of the test statistic is not easily
computed. They are used in candidate-gene and genome-wide association studies, as
well as in family-based association tests.
In our case of CNV-association testing, a permutation test gives a simple way to
compute the sampling distribution for the test statistic, under the null hypothesis
that a set of genetic variants has absolutely no effect on the outcome. Permutation
involves randomly repeated "shuing" of the phenotype trait values and thus creates
many samples under the null hypothesis to estimate the sampling distribution of the
test statistics. I formally define the kernel permutation method introduced in Sec-
tion 3.2.1 and show that it preserves family-wise error rate for the problem of CNV
association testing. In this section below, I will fully describe this approach and prove
that it preserves type I error and controls FWER theoretically.
For a given set of test results {pj} and tj = f(pj), consider the statistic
Tmax = max
j
{Tj}, (3.1)
where Tj is the kernel-based aggregation of tj in a window. If signs of the tests are
available , with results {pj, sj}, we use Tmax = maxj{|Tj|}.
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To estimate the null distribution of Tmax, we use a permutation approach, gen-
erating up to n! unique draws {T (b)max}Bb=1 from the permutation distribution of Tmax.
The procedure is as follows. At any given iteration, draw a random vector of pheno-
types y(b) by permuting the original vector of phenotypes. That is, reassigning each
phenotypic trait to a new individual while retaining the individual's genetic intensi-
ties. Under the null of no association between intensities and phenotypes, randomly
shuing the phenotypic values across individuals will not alter the distribution of the
test statistic. Next, carry out marker-level tests of association between the original
CNV intensities and the permuted vector of phenotypes, obtaining a vector of permu-
tation test results {p(b)j }. Finally, apply the kernel aggregation procedure described in
Section 2.2.1 to obtain {T (b)j } and T (b)max. The entire procedure is repeated B times. In
this way, we reach the independence between intensities and phenotypes for each iter-
ation such that all permutated results {T (b)max}Bb=1 are equally likely and exchangeable.
Computing appropriate test statistics from each shuing, we are essentially sampling
from a null distribution corresponding to no association between intensities and trait
values. We may then use the empirical CDF of these draws from the permutation
distribution of Tmax to obtain the estimate Fˆ0. Thus, we obtain a global test for the
significant presence of a CNV-phenotype association based on p = 1− Fˆ0(Tmax). By
preserving the correlation structure of the original CNV intensities, this approach
does not rely on any assumptions of exchangeability or independence across neigh-
boring markers, and is thereby able to preserve the type I error rate of the testing
procedure, unlike the other approaches described in Section 3.2.1. I now formally
present this result, the proof of which appears as below.
Theorem 1. Let H0 denote the hypothesis that the phenotype, yi, and the vector of
CNV intensities, xi, are independent. Then, using the permutation approach described
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above for any of the kernel aggregation approaches in Section 2.2.1, for any α ∈ (0, 1),
Pr(Type I error) ≤ α. (3.2)
Proof of Theorem 1. Let P denote the set of all possible permutations of {yi}, F0
the CDF of Tmax over P , and F−10 its generalized inverse. Also, let φ(X,y) = 1 if
Tmax(X,y) > F
−1
0 (1− α) and 0 otherwise.
Now, note that under the null hypothesis that xi and yi are independent,
P (X,y) =
∏
i
P (xi, yi)
=
∏
i
P (xi)P (yi)
= P (X,y∗)
for all y∗ ∈ P . Thus, E0φ(X,y∗) is a constant for all y∗ and
E0 {φ(X,y)} = 1
n!
∑
y∗∈P
E0φ(X,y∗)
= E0
1
n!
∑
y∗∈P
φ(X,y∗)
≤ α,
where the term inside the expectation in the second line is less than or equal to α for
all X and y by the construction of the test.
The permutation test is guaranteed to have the correct desired false positive rate
(Type I error) regardless of the distributional characteristics of the data at hand. It is
worth pointing out that the above theorem is proven for the case in which all permu-
tations of {yi} are considered. In practice, as it is usually impractical to consider all
permutations, one can generate only a random samples of these permutations from
the set of all permutations of the data. However, by the law of large numbers, the
above conclusion still holds approximately, and may be made as precise as necessary
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by increasing the value of B, the number of permutations evaluated. For the numer-
ical results in Section 3.4, we use B = 1, 000.
The global test above aims to quantify and represent compelling evidence for a
CNV-phenotype association among the whole chromosome. However, it is of limited
practical benefit in the sense that it does not indicate the location of the associated
CNV. Thus, we could consider the following equivalent marker-level test: declare sig-
nificant evidence for the presence of a CNV-phenotype association at any marker for
which Tj > F−10 (1 − α). Below, we state the corollary to Theorem 1 for the kernel
permutation method, viewed as a multiple testing procedure for each marker.
Corollary 1. Let H0j denote the hypothesis that the phenotype, yi, and the CNV
intensity at marker j, Xij, are independent. Then, under the global null hypothesis
that yi is jointly independent of {Xij}, for any α ∈ (0, 1),
Pr(At least one Type I error) ≤ α (3.3)
using the permutation approach described above and Tj > F
−1
0 (1 − α) as the test
function for H0j. In other words, the testing procedure described above controls the
FWER in the weak sense at level α.
It is worth noting that the procedure above controls the FWER only in the weak
sense  in other words, that it limits the probability of a false declaration of a CNV
only under the global null hypothesis that there are no CNVs associated with the
outcome. Typically in multiple testing scenarios, this is undesirable and strong con-
trol is necessary. However, in the case of CNV-phenotype association, strong control
is impractical, as it would imply that a method not only identifies CNV-phenotype
associations, but can perfectly detect the genomic boundary of any associated CNV.
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This is an unrealistic requirement; in practice, there is no way to prevent the possibil-
ity that a detected CNV-phenotype association may spill over beyond the boundary
of the CNV.
3.3 Gemcitabine study
In this section we describe a pharmacogenomic study of gemcitabine, a commonly
used chemotherapeutic agent in many kinds of cancer. I begin by describing the
design of the study [35], then analyze data from the study using the proposed kernel-
based aggregation method by permutation. This data will also be used to create
spike-in simulated data sets for power comparison of simulation studies in Section 3.4.
The gemcitabine study was carried out on the Human Variation Panel, a model
system consisting of cell lines derived from Caucasian, African-American and Han
Chinese-American subjects (Coriell Institute, Camden, NJ). Gemcitabine cytotoxic-
ity assays were performed at eight drug dosages (1000, 100, 10, 1, 0.1, 0.01, 0.001,
and 0.0001 uM) [60]. Estimation of the phenotype IC50 (the effective dose that kills
50% of the cells) was then completed using a four parameter logistic model [61].
Marker intensity data for the cell lines was collected using the Illumina HumanHap
550K and HumanHap510S at the Genotyping Shared Resources at the Mayo Clinic
in Rochester, MN, which consists of a total of 1,055,048 markers [62, 63]. Raw data
were normalized according to the procedure outlined in [64].
172 cell lines (60 Caucasian, 53 African-American, 59 Han Chinese-American)
had both gemcitabine cytotoxicity measurements and genome-wide marker intensity
data. To illustrate the application of the kernel permutation approach, we selected
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one chromosome (chromosome 3) from the genome-wide data. To control for the pos-
sibility of population stratification, which can lead to spurious associations, we used
the method developed by [65], which uses a principal components analysis (PCA)
to adjust for stratification. At each marker, a linear regression model was fit with
PCA-adjusted IC50 as the outcome and intensity at that marker as the explanatory
variable; these models produce the marker-level tests.
We analyzed these data using the kernel-based approach described in Section 2.2
with a bandwidth of 50 markers and the log transformation. The results are shown
in Figure 3.2. Note the presence of a peak at 102.6 Mb; this genomic region was also
illustrated in Figure 1.1. The red line indicates the FWER-controlled, chromosome-
wide significance threshold at the α = 0.1 level. As the figure indicates, there is in-
sufficient evidence in this study to establish a CNV association involving response to
gemcitabine (p = 0.16) after controlling the chromosome-wide FWER. Other choices
of bandwidth and transformation produce qualitatively similar, although somewhat
less significant, results.
Copy number variation in the region of chromosome 3 at 102.6 Mb, which is in
close proximity to the gene ZPLD1, has been found by [66] to be associated with
childhood obesity. An earlier analysis of this data by [35] indicated suggestive ev-
idence that this region harbors a CNV association with gemcitabine response but
lacked a formal way to control the error rate at the chromosome-wide level. This
example illustrates the need for the more rigorous approach we develop here. The
lack of significance in this example is perhaps not surprising, in that 172 subjects is
a relatively small sample size for a CNV association study.
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Figure 3.2: Analysis of the gemcitabine data (Chromosome 3) using the proposed
kernel aggregation method. The kernel aggregations Tj are plotted against chro-
mosomal position. The red line indicates the cutoff for chromosome-wide FWER
significance at the α = .1 level.
3.4 Simulation
3.4.1 Spike-in data design
As illustrated, the permutation approach is a valid way to assess the significance of
the proposed kernel-based CNV-phenotype association test. In order to study the
power of the proposed approach to detect CNV-phenotype associations, we simulate
CNVs and their corresponding intensity measurements, LRR. The validity and accu-
racy of our conclusions rely on how realistic the simulated data is, so we need to put
careful thought into simulating this data in as realistic a manner as possible. Here in
the thesis, I use the spike-in design that is described in [35].
The basic design of our simulations is to use real data from the gemcitabine study
described in [35], spike a signal into it, then observe the frequency with which we
can recover that signal. We fit a circular binary segmentation model [30, 31] to esti-
mate underlying mean intensity for every marker along the chromosome. Then We
calculate the residuals by subtracting the actual intensity measurement from the es-
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timated mean. These residuals form a matrix representing measurement errors from
real data and we use these residuals to simulate our LRR noise. We pick chromosome
3 of the gemcitabine pharmacogenomic study for simulation and this residual matrix,
denoted R, has 172 rows (one for each cell line) and 70,542 columns (one for each
marker).
Our simulations involve short genomic regions containing 200 markers in which a
single CNV is either present or absent. The length of the CNV varies from 10 to 50
markers. We randomly select residuals from the above residual matrix to simulate
LRR noise over our study genomic regions. Then add in a signal. Letting i denote
subjects and j denote markers, the following variables are generated: zi, an indicator
for the presence or absence of a CNV in individual i; xij, the intensity measurement
at marker j for individual i; and yi, the phenotype for subject i. We focus here on
a random sampling design in which the outcome is continuous. In the random sam-
pling design, the CNV indicator, zi, is generated from a Bernoulli distribution, where
γ = Pr(zi = 1) is the frequency of the CNV in the population. Meanwhile, yi|zi is
generated from a normal distribution whose mean depends on zi.
For each simulated data set of every subject, 200 markers were randomly selected
from the columns of R. The measurement error for simulated subject i was then
drawn from the observed measurement errors at those markers for a randomly chosen
row of R. The random selection of markers would remove the possibility of bias from
correlation among the intensities of neighboring markers. Thus, within a simulated
data set, all subjects are studied with respect to the same genetic markers, but the
markers vary from data set to data set. Simulating the data in this way results in
all the features of outliers, heavy-tailed distributions, skewness, unequal variability
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among markers, and unequal variability among subjects that are present in real data.
The intensity measurements {xij} ,as mentioned, derive from these randomly ob-
served residuals in the real data. To the noise, we add a signal(mean structure) that
depends on the presence of the simulated CNV, zi. The added signal is equal to zero
unless the simulated CNV region; otherwise the added signal is equal to the standard
deviation of the measurement error times the signal to noise ratio. Thus, adding the
signal value to independent measurement errors, we generate our simulated intensi-
ties. Choosing an appropriate signal to noise ratio is less obvious. For the amount of
noise, the standard deviation of the residual values is 0.9. Signal, however, depends
on a number of unknown and poorly understood factors. We would simulate CNVs
with a signal of mean shift 0.72 and thus employed a signal to noise ratio of 0.8 for
simulation, which corresponded roughly to a medium-sized detectable signal based
on our inspection of the gemcitabine data. In such a construction, phenotype and
intensity measurement are conditionally independent given the latent copy-number
status zi. An illustration of the spike-in process is given in Figure 3.3.
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Figure 3.3: Illustration of spike-in simulation design. Left: The noise, randomly
drawn from among the estimated measurement errors for a single cell line. Middle:
The spiked-in signal. Right: The resulting simulated data.
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Using this procedure, the simulated data appears similar to the real data. For the
Illumina Human1M-Duo BeadChip, which has a median spacing of 1.5 kb between
markers, 200 markers corresponds to simulating a 300 kb genomic region. We varied
the length of the CNV from 10 to 50 markers, corresponding to a size range of 15 to 75
kb. For the simulations presented in the remainder of this section, we used a sample
size of n = 1, 000 and an effect size (mean divided by standard deviation) of 0.4 for the
continuous outcome. All association tests are conducted with type I error rate of 0.05.
Using such simulation data, we compare the power while varying CNV sizes, trans-
formations of p-values or kernels. For each setting, 1000 independent data sets are
generated and analyzed. Power is defined as the fraction of data sets in which CNV-
phenotype association is declared. The association test at each marker would derive
from a linear regression model between intensity and phenotype. One would prefer a
method that not only detects CNV associations but also identifies their boundaries.
Here I focus only on detection of phenotype-associated CNV in my thesis.
3.4.2 Comparison of transformation
For the various transformations proposed in Sections 2.2.2 and 2.2.3 for different as-
sociation tests, we evaluate the relative impacts of transformation and association
direction on power. First, we here set CNV frequency to be 10%. In order to isolate
the effect of transformation, we set bandwidth of the kernel to be the "optimal band-
width", which is chosen to match the number of markers for the underlying CNV
and thus results in the maximum power to detect a CNV-phenotype association. In
practice this approach is not feasible since the size of the underlying CNV is unknown.
41
Signed Unsigned
0.2
0.4
0.6
0.8
10 20 30 40 50 10 20 30 40 50
Markers
Pr
(D
ete
cti
on
) Transformation
Log
p
Z
Figure 3.4: Effect of transformation choice and direction of association on power.
Population CNV frequency was set to 10%; optimal bandwidths used.
The results in Figure 3.4 demonstrate the impact of transformation choice on
power. The figure illustrates a basic trend that held consistently over many CNV
frequencies and bandwidth choices. Various choices of transformation produce con-
sistent results for both association test settings by comparing the left and right halves
of the figure. Furthermore, if the direction is available along with the test, all trans-
formations by incorporating the direction of association perform much better than
ignoring the direction of association with regard to power. Besides, although various
transformations do not alter power dramatically, the normalizing transformation (Z)
is the most powerful for signed test results, while the log transformation obtains the
highest power for unsigned tests. In the results that follow, unless otherwise specified,
I employ the normalizing transformation for signed test results and the log transfor-
mation for unsigned tests.
3.4.3 Comparison of kernel choice
As illustrated in Section 2.2.1, there are two important factors with regards to kernel.
Thus here in this section, we examine two aspects of kernel choice: bandwidth imple-
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mentation (constant-width vs. constant-marker) and kernel shape (flat vs. Epanech-
nikov). When all markers are equally spaced, the constant-width and constant-marker
kernels are equivalent. To evaluate the impact of bandwidth on power when markers
are unequally spaced, we selected at random a 200-marker sequence from chromosome
3 of the Illumina HumanHap 550K genotyping chip and spiked in CNVs of various
sizes. We specified five bandwidth corresponding to window size varying from 10 to
50 markers. The optimal bandwidth (either in terms of the number of markers or
base pairs spanned by the underlying CNV) was chosen for each method.
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Figure 3.5: Effect of kernel choice on power. Left: Constant-width kernel vs.
constant-marker kernel. Right: Flat vs. Epanechnikov kernel. In both plots, popula-
tion CNV frequency was 10%, test results were unsigned, and the log transformation
was used.
The left side of Figure 3.5 presents the results of this simulation comparing ker-
nels with two different bandwidth implementations. The constant-marker approach
is substantially more powerful through all bandwidth settings. When the number of
markers within each window is not held constant, the aggregation measure Tj is more
highly variable for some values of j than others. This causes the null distribution of
Tmax to have thicker tails, which in turn increases the p-value for the observed Tmax,
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thus lowering power. This phenomenon manifests itself most dramatically for small
bandwidths. Consequently, throughout the rest of this chapter, we employ constant-
marker kernels for all analyses.
The right side of Figure 3.5 presents the results of comparing the kernel shape
between the flat kernel described in (2.2) and the Epanechnikov kernel described in
(2.3). We make several observations: (1) The shape of the kernel has only a lim-
ited effect on power; the performance of two different kernel functions with regard to
power seems similar. (2) The kernel approach is relatively robust to choice of band-
width; even 5-fold differences between the test bandwidth and optimal bandwidth do
not dramatically reduce power. (3) Nevertheless, the optimal bandwidth does indeed
perform best when the number of markers included in the kernel matches the true
number of markers spanned by the CNV. A larger window may include too many
non-informative markers and lead to a reduction in testing power; a smaller window
may ignore informative markers and thus decrease the power. Thus, choosing dif-
ferent bandwidth would change the power. (4) The Epanechnikov kernel is slightly
more robust to choice of bandwidth than the flat kernel is. This makes sense, as the
Epanechnikov kernel gives less weight to the periphery of the kernel.
3.4.4 Comparison of kernel-based aggregation and variant-level testing
Lastly, we compare the kernel-based aggregation approach with variant-level test-
ing. To implement variant-level testing, each sample was assigned a group (variant
present or variant absent) on the basis of whether a CNV was detected by CBS.
A two-sample t-test was then carried out to test for association of the CNV with the
phenotype. This variant-level approach was compared with kernel-based aggregation
44
of marker-level testing for a variety of bandwidths. The results are presented in Fig-
ure 3.6.
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Figure 3.6: Power comparison of variant-level testing (using CBS for CNV calling)
with marker-level testing (using kernel-based aggregation).
For rare CNVs (5% population frequency), the power of the variant-level approach
and the aggregated marker-level approach are comparable. However, for more com-
mon CNVs, the marker-level approach offers a substantial increase in power. For the
most part, this increase in power persists even when the bandwidth is misspecified.
Only when the bandwidth was too small (selecting a 10-marker bandwidth for a 50-
marker CNV) did the variant-level approach surpass marker-level aggregation.
Generally speaking, these results are consistent with the findings reported in [35],
who found that variant-level tests have optimal power relative to marker-level tests
when CNVs are large and rare; conversely, marker-level tests have optimal power rela-
tive to variant-level tests when CNVs are small and common. This is understandable
given the limited accuracy of calling algorithms for small CNVs.
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Comparing the results in Figure 3.6 with the results of Breheny et al. [35], who
aggregated marker-level tests by applying CBS to the p-values as described in Sec-
tion 3.2.1, we find that the kernel approach is a substantially more powerful method
for aggregating marker-level tests than a change-point approach. Specifically, Breheny
et al. found that the change-point approach had very low power at 5% frequency 
much lower than the variant-level approach. On the other hand, in the same setting
we find that the kernel approach is comparable to, and even slightly more power-
ful than, the variant-level approach. Furthermore, as discussed in Section 3.2.1, a
change-point analysis of marker-level tests also relies on exchangeability, which does
not always hold. Thus, the methods developed here in the thesis are both more
powerful and achieve better control over the FWER than the change-point analysis
described in [35].
A potential drawback of the kernel approach is the need to specify a bandwidth.
This makes the robustness of the method to bandwidth misspecification, as illustrated
in Figure 3.6, particularly important because in practice it is difficult to correctly
specify the bandwidth a priori. Indeed, it is possible that multiple CNVs associated
with the outcome are present on the same chromosome and have different lengths.
A method that is not robust to bandwidth would be incapable of detecting CNVs.
Generally speaking, a bandwidth of roughly 30 markers seems to provide good power
over the range of CNV sizes that we investigate here.
Copyright© Yinglei Li, 2014.
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Chapter 4 Correlation Method and Its Family Wise Error Rate Control
4.1 Introduction
I introduced kernel-based aggregation method to determine the CNV-phenotype asso-
ciation. As p-values are correlated with each other among markers, it is complicated
to estimate the exact null distribution when applying the method. There is no specific
computational approaches developed to estimate the null distribution when apply-
ing the kernel-based method. I applied a permutation procedure to our kernel-based
framework in Chapter 3. I demonstrated that this method provides evidence of asso-
ciation between phenotype and genotype while preserving accurate FWER. However,
the permutation approach has its own limitations as mentioned earlier. One impor-
tant drawback for analysis is the computational burden of the method. For simple
tests such as the linear regression tests we used in the gemcitabine study, the burden
is quite manageable. On our machine (using an Intel Xeon 3.6 GHz processor), it
takes under a second to perform the 70,542 marker-level tests on chromosome 3 and
under 0.1 seconds to perform the kernel aggregation. Carrying out 1,000 permutation
tests took 1,000 times longer: 15 minutes to carry out all the permutation tests and
21 seconds to perform all the kernel aggregation. Extrapolating a genome-wide anal-
ysis would take 3.5 hours. These calculations, however, are for simple marker-level
tests and a fairly small sample size (n = 172). Larger studies will increase the com-
putation burden linearly (i.e., doubling the subjects should double the computing
time), but more complicated marker-level tests based on nonlinear, mixed-effects, or
mixture models would require substantially more time. But it is worth pointing out
that kernel aggregation itself does not consume time but the estimation of the null
distribution. As seen in Figure 3.2, the black dots may be calculated rapidly; the red
line is what requires the permutation testing. It is worth further research to discover
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ways to speed up the approach.
Since p-values are statistically dependent, the exact null distribution relies on the
correlation structure of p-values. In this chapter, a correlation-based approach with a
model-based formulation that avoids the need for permutation testing was considered
to apply to our kernel-based method in order to speed up the analysis. I present
and demonstrate the procedure in details to approximate the joint distribution of the
test statistics. I show through simulations that this approach not only provides an
accurate error control, but also is much faster than the permutation approach.
4.2 Basic idea about correlation method
4.2.1 Correlation approach
Applying kernel-based aggregation of marker-level association test, we consider a two-
stage procedure. From association testings for every marker, we obtain a set of test
results {pj}. Then, when considering quantifying whether or not the data represent
compelling evidence for a CNV-phenotype association we use the statistic
Tmax = max
j
{Tj}, (4.1)
where Tj is the kernel-based aggregation of p-values in a window. If the tests are
directional, with results {pj, sj}, we use Tmax = maxj{|Tj|}.
To obtain the null distribution of Tmax, we present an alternative to the permuta-
tion approach, which is a correlation-based procedure. We now formally present this
procedure to fit our kernel-based aggregation framework as follows and show that it
preserves the family-wise error rate for the problem of CNV association testing.
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Step 1: Estimate a correlation matrix Σ that defines the relationship among z-
statistics under null. First of all, we assume that the correlation completely describes
the dependence between the series of z-statistics. If Σ is positive definite, then the
Cholesky decomposition, Σ = CCT , can be obtained. In many situations, the corre-
lation of the series of original p-values is complicated to estimate from real data. I
will later give details of calculating Σˆ for the CNV-phenotype association study under
assumption of simple linear model.
Step 2: Generate vectors of dependent z-values mimicking the original z-values from
the real data. Geometrically, a symmetric and positive definite matrix C will trans-
form uncorrelated variables to dependent z-values. According to [40], generate a ran-
dom vector U from independent uniform (0,1) distribution and let Z = Φ−1(1 − U)
where Φ(.) was the cumulative distribution function of a standard normal random
variable. Given a random vector of i.i.d uncorrelated standard normal variables Z,
the Cholesky transformation maps the variables Z into variables CZ with covariance
matrix V ar(CZ) = CV ar(Z)CT = CICT = Σ. Thus, CZ reflects the distribution of
test statistic under null that there is no association between genotype and phenotype.
Step 3: Construction of empirical null distribution of the test statistic. Based on the
multivariate normal distribution CZ described in Step 2, we could create series of test
statistics from such distribution. If the direction of association is available, we could
calculate p-values for both signed and unsigned cases. In this way, we may generate an
arbitrary number of vectors of dependent p-values among markers. It is computation-
ally less demanding since it does not involve repeated analysis of simulated datasets.
For each vector of dependent p-values for the bth Monte Carlo sample, we calculate
the proposed test statistic applying kernel-based method to yield {T (b)max, b = 1, ..., B}
for any choice of transformation and kernel in (2.1). Finally, we use the empirical
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CDF of those draws to obtain the estimate Fˆ0 =
∑
1≤b≤B I[T
(b)
max ≤ x]/B.
Step 4: The calculation of the empirical overall p-value. By the estimation of null
distribution function in Step 3, we obtain a test for the presence of a CNV-phenotype
association based on p = 1− Fˆ0(Tmax).
4.2.2 Replacing correlation among z statistics with correlation of inten-
sities
It is worthy to point out that this approach depends on the estimation of correlation
matrix of z-statistic under null. But it is always complicated to estimate. Suppose
our analysis data consist of a set of marker genotypes together with phenotypic trait
values measured on each individual (X i, yi), i = 1, 2, ...n, where X i = (Xi1, ..., XiJ)T
is a vector of the copy number intensities for every marker for subject i and yi is the
phenotype for subject i. Assume simple linear regression y = β0 + β1jxj +  between
phenotype y as the outcome and intensity xj at jth marker as the explanatory vari-
able for every marker, where  has a normal distribution with mean 0 and standard
deviation σ. By standardization, we define xij − x¯j = x′ijsdxij and yi − y¯ = y′isdyi ,
where we denote standardized x′ij and y
′
i.
Under the simple linear regression model, we have the z-statistics under H0:
Zj =
βˆ1j − 0
s.e.
=
∑
(xij−x¯j)(yi−y¯)∑
(xij−x¯j)2
σˆ
√
1/
∑
(xij − x¯j)2
=
∑
sdxijx
′
ijsdyiy
′
i
σˆ(n− 1)sd2xij
√
(n− 1)sd2xij
=
∑
x′ijy
′
i√
(n− 1) ,
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where
∑
(xij − x¯j)2 = (n− 1)sd2xij and also σˆ = sdyi .
Now, correlation between z statistics of any two markers is simplified and we get
cor(zj, zk) = cor(
∑
x′ijy
′
i√
(n− 1) ,
∑
x′iky
′
i√
(n− 1))
= cor(
∑
x′ijy
′
i,
∑
x′iky
′
i)
= cor(
∑
x′ij,
∑
x′ik),
since under the null hypothesis that xij and yi are independent.
Therefore,
cor(zj, zk) = cor(
∑
x′ij,
∑
x′ik)
= cor(xj,xk)
We summarize and present the following theorem.
Theorem 2. Assume a simple linear regression model was fit at each marker between
phenotype and genotype. Let H0j denote the hypothesis that the phenotype, yi, and
the CNV intensity at marker j, Xij, are independent. Then, under the global null
hypothesis H0 that yi is jointly independent of {Xij}, correlation structure among
z statistics under H0 exactly equals the correlation matrix of the intensities among
markers under assumption of simple linear model.
By Theorem 2, the correlation structure among z-values under H0 is the same
as the correlation matrix of the intensities under assumption of simple linear model
between intensities and phenotypes for every marker. It is worth to note that the
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estimate of correlation structure might depend on the knowledge of model assump-
tion between intensities and phenotype. Then we need the fact that correlation is
approximately invariant under monotone transformations [40]:
Cor(g(Xi), g(Xj)) ≈ [g
′(µ)]2Cov(Xi, Xj)√
[g′(µ)]4V ar(Xi)V ar(Xj)
= Cor(Xi, Xj) (4.2)
For some modelings like logistic regression, the z-value is a monotone function of
z-value of linear regression. Applying (4.2), their correlation should be more or less
equivalent. Thus, we could extend to some other model assumption between phe-
notype and genotype by (4.2). If the z-values for some model assumption is highly
monotone in comparison with linear regression, we could get approximately the same
correlation estimate as the estimate under linear modeling.
4.2.3 Estimate of correlation matrix of intensities among markers
Theorem 2 provides a good way to estimate the correlation structure of z-statistic.
Given the structure of intensities among markers, we could use the sample correlation
of intensities to estimate the correlation matrix of z-statistic under null hypothesis
of no CNV-phenotype association. But estimation of correlation matrix and applica-
tion of such approach would be easy to achieve and would be well-applied when the
number of features is small. When the number of markers is large, it would cause
problems. First of all, the high dimensions J × J matrix calculation will bring sta-
tistically efficiency and computational problem. It always increases the computation
burden and might run out of memory for high dimensions. Besides, the algorithm in
section 4.2.1 requires Cholesky decomposition, which gets slower for high dimension
matrix. Hence, estimation of large-scale covariance matrix from real genomic data
become an ubiquitous problem. There are a lot of methods proposed in the literatures
for estimation under such case, including the spectral decomposition, Bayesian meth-
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ods, modeling the matrix-logarithm, nonparametric smoothing, and banding/thresh-
olding techniques [6773].
It would be important to extend our research to high dimension, which is the typ-
ical situation in real data. Therefore, I develop different approaches to estimate the
restricted correlation matrix for computation convenience in different circumstances
for high dimensions of features. I will talk about it in the following sections.
4.3 Extending correlation approach to small n, large J setting
For genomics and transcriptome analysis, estimation of large-scale covariance or cor-
relation matrices is a common problem. From a microarray experiment or CNV data,
J markers are being analyzed with J perhaps in the order of 1,000 to 10,000 and thus
a correlation of size J × J has to be calculated. For analysis involving real data,
we do not know where CNVs are located before analysis. We normally collect more
and more intensity data that might include the possible CNV to detect the CNV-
phenotype association and detect the CNV location. Hence, it is pretty common
to involve thousands or millions of markers from part of or the whole chromosome.
Meanwhile, it often encounters with a limited number of samples n. A common key
problem for all such data is that how we should obtain an accurate and reliable esti-
mate of the population covariance matrix when a data set includes a large number of
variables but only contains comparatively few samples (n << J). Under such small
n, large J setting, singular value decomposition (SVD) and principal component
analysis (PCA)are valuable tools and common techniques for analysis of such multi-
variate data.
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Principal component analysis (PCA) (Jolliffe 1986) is a popular data-processing
and dimension-reduction technique for taking high-dimensional data, and using the
dependencies between the variables to represent it in a more tractable, lower-dimensional
form, without losing too much information. It is a widely used mathematical tool for
high dimension data analysis. PCA provides a guideline for how to reduce a complex
data set to one of lower dimensionality to reveal any hidden, simplified structures
that may underlie it. It extracts the most important information in such a way as
to highlight their similarities and differences from the data table and compress the
size of the data set by keeping only this important information. Then it can simplify
the description of the data set and analyze the structure of the observations and
the variables. The other main advantage of PCA is that once you have found these
patterns in the data, and you compress the data, ie. by reducing the number of di-
mensions, without much loss of information. Overall, PCA is one of the simplest and
most robust ways capable of reducing dimensions and revealing relationships among
data items. It has been applied in numerous fields such as engineering, biology, and
social science. Some interesting examples include handwritten zip code classification
(Hastie,Tibshirani, and Friedman 2001) and human face recognition (Hancock, Bur-
ton, and Bruce 1996). Recently PCA has been used in gene expression data analysis
(Alter, Brown, and Botstein 2000). Hastie et al. (2000) proposed the so-called gene
shaving techniques using PCA to cluster highly variable and coherent genes in mi-
croarray datasets. Strictly speaking, singular value decomposition is a matrix algebra
trick which is used in the most common algorithm for PCA. PCA can be computed
via the singular value decomposition(SVD) of the data matrix.
According to Theorem 2, correlation structure among z-statistics Σ under H0
exactly equals the correlation matrix of the intensities among markers. Let X be
n × J original intensity matrix, where n is the sample size and J is the number of
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total markers. Applying SVD method on it, the singular value decomposition of X
is the factorization of X into the product of three matrices,
X = UDV T , (4.3)
where U is n × n orthogonal matrix with UTU = I, V is J × J orthogonal matrix
with V TV = I. We could partition U = (u1, ..., un) and V = (v1, ..., vJ), where uj
denote the jth left singular vector and vj denote the jth right singular vector. D is
n× J diagonal matrix with diagonal entries (D11 = σ1) ≥ (D22 = σ2) ≥ ... ≥ (Drr =
σr) ≥ 0. Here σ1, σ2, ..., σr are called the singular values. The singular values are
sorted from high to low, with the highest singular value in the upper left index of the
matrix. If rank(X) = r, then it equals to the number of non-zero singular values on
the diagonal. Also, the column space of X is spanned by the first r columns of U and
the last n− r columns of U span the null space of XT . Meanwhile, the row space of
X is spanned by the first r columns of V and the null space of X is spanned by the
last J − r columns of V .
XTX = (UDV T )TUDV T = V DUTUDV T = V D2V T , (4.4)
XXT = UDV T (UDV T )T = UDV TV DUT = UD2UT , (4.5)
where XT is the conjugate transpose of X. The right hand sides of these relations de-
scribe the eigenvalue decompositions of the left hand sides. Consequently, the squares
of the non-zero singular values of X are equal to the nonzero eigenvalues of either
XXT or XTX. Thus XXT which is n × n and XTX which is J × J will share n
eigenvalues when n < J and the remaining J − n eigenvalues of XTX will be zero.
The columns of V , which are called right singular vectors, are the eigenvectors of
XTX and the columns of U ,called left singular vectors, are eigenvectors of XXT .
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Either the singular vectors of the singular values (or both) are called principle compo-
nents. The matrix D does not have to be square. Note that for a square, symmetric
matrix X, singular value decomposition is equivalent to diagonalization, or solution
of the eigenvalue problem. SVD decomposes a matrix into a set of rotation and scale
matrices, which is used in computing the pseudoinverse, matrix approximation, and
determining the rank, range and null space of a matrix.
Let Dr =

σ1
. . .
σr
, and hence (4.3) will become
X =
(
Ur Un−r
)Dr 0
0 0

 V Tr
V TJ−r
 = UrDrV Tr , (4.6)
using Ur =
(
u1 · · · ur
)
and Vr =
(
v1 · · · vr
)
. This thin SVD is equivalent to
the ordinary SVD. Applying (4.6), any n×J real matrix equivalent to the product of
a column-orthogonal n× r matrix, a diagonal r× r matrix where the elements sorted
in descending order, and a column-orthonormal J×r matrix. It is a useful result since
we could reduce the dimension of the ordinary large matrix into product of simplified
matrix. In small n, large J setting, the number of the non-zero singular values of
such a large matrix X, which equals the rank of X, would be smaller or equals to
min(n, J) = n. If we know the rank of the intensity matrix to be r, we could get the
thin SVD of X. Thus, applying such procedure, we could deal with smaller matrix
with the optimal low rank instead of the large matrix.
For calculating the covariance matrix of intensities, there is a direct relation be-
tween PCA and SVD in the case where principal components are calculated from the
covariance matrix. For PCA to work properly, the first step in PCA is to move the
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origin to mean of the data. In our case, we could achieve the first step by finding
means of every marker by averaging the columns of X. We then subtract the mean
intensity from each intensity of the data set (ie each row of X) to create the mean cen-
tered data vector. This produces a data set whose mean is zero for every marker. It
is very easy to compute the covariance matrix from the mean centered data matrix.
Furthermore, we apply the method to the correlation rather than the covariances.
For correlation matrix, the off-diagonal elements are on the same scale. Also, the
correlations derived from covariance estimator are independent of scale and location
transformations of the underlying data matrix. Due to such distinct advantages, it is
better to work on correlation matrix, which we denote Σ. To achieve the correlation
matrix, we need to standardize the original data matrix. For every element of the
data matrix xij, we apply the standardization.
x′ij =
xij − X¯j
sXj
, (4.7)
where X¯j and sXj are mean and sample standard deviation of jth column intensities
for jth marker. For the standardized data matrix which we denote as X, we could
get the sample correlation matrix.
Σ =
1
n− 1(X
T
X) (4.8)
Applying equation (4.6), here the sample correlation matrix would be
Σ =
1
n− 1(X
T
X) =
1
n− 1(V D
2V T ) =
1
n− 1(VrD
2
rV
T
r ) (4.9)
The diagonalization of XTX yields V , which also yields the principal components of
correlation matrix. So, the right singular vectors vk are the same as the principal com-
ponents of correlation matrix. Using the decomposition above, we can identify the
eigenvectors and eigenvalues for XTX as the columns of V and the squared diagonal
elements of D, respectively. Clearly, the eigenvalues and eigenvectors of correlation
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matrix is the same as the eigenvalues and eigenvectors of XTX. Meanwhile, the lat-
ter shows that the eigenvalues of XTX must be non-negative. Therefore, the sample
correlation matrix here is positive semi-definite.
It is a common setting to have much more markers than samples, n J . The J×J
correlation matrix itself is therefore very unpleasant to work with because it is very
large under small n, large J setting. However, by Theorem 2, it suffices to decom-
pose a smaller matrix. In such setting, it is known that XXT which is n×n and XTX
which is J × J will share n eigenvalues and the remaining J − n eigenvalues of XTX
are all zeros. Therefore, for the eigenvalues which are zeros, we can essentially discard
those eigenvalues and the corresponding eigenvectors, hence reducing the dimension-
ality of the new basis. Instead of dealing with J × J matrix for Σ, we could focus on
the smaller matrix with dimensions n×n for correlation matrix without losing infor-
mation since the other J − n dimensions don't contain any additional information.
It will be an amazing improvement in speed of computing the estimated correlation
matrix. For example, for a 174×70, 000 intensity matrix, we don't need to work with
70, 000× 70, 000 correlation matrix, which we might not be able to store in our com-
puters. Instead, by the decomposition, the 174× 174 matrix, which is a lot faster to
obtain, is enough to estimate the correlation matrix. It's really a great result that the
estimation of correlation matrix has nothing to do with the large J dimensions but
instead only depends on sample size for the matrix dimension. Thus, the smaller n
is, the much faster to estimate the correlation matrix of intensities. For standardized
intensities X, the correlation matrix is equivalent to the variance-covariance matrix.
It is worthy to notice that the rank of the variance-covariance matrix is n while the
correlation matrix only has a rank of n − 1 since it is restricted to have 1's along
the diagonal. Therefore, following the above equation (4.9), we obtain the estimated
correlation matrix 1
n−1(V D
2V T ) and it is equivalent to 1
n−1VrD
2
rV
T
r in a much smaller
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dimensions, where r = n−1. we only need to know the first n−1 left singular vectors.
Meanwhile, the decomposition has nothing to do with the right singular vectors uk.
Thus, we could reduce the dimensions a lot and only select n−1 vectors for calculation
of the correlation matrix. Obviously, the correlation matrix is obtained in a much
faster speed. As here the correlation matrix is positive semi-definite, we can denote
Σ = CCT . By decomposition,C = 1
sqrt(n−1)(V DV
T ). Thus, given a random vector of
i.i.d uncorrelated standard normal variables Z, variables CZ follows a multivariate
normal distribution with covariance matrix V ar(CZ) = CV ar(Z)CT = CICT = Σ.
This method works especially well for small n, large J setting. The small n
makes dimension reduction for calculating correlation matrix and hence speed it up
a lot compared to directly estimating the large correlation matrix. The comparisons
of performance will be shown in the later sections.
4.4 Extending correlation approach to large n, large J setting
There is a computation burden problem to estimate the high-dimensions correlation
matrix and use such large correlation matrix to generate the multivariate normal
random variables under null hypothesis. The time consumption increases as the di-
mension increases. I have proposed SVD decomposition method for the case of small
n, large J, which leads to the dimension reduction. Thus, we only need to deal with
low-dimensional matrix with dimension depending on the small n to estimate the
correlation matrix. However, this method is insufficient when n gets large. Instead,
we hope to impose a low-dimensional structure on the estimator and aim to get a
sparse correlation matrix to decrease the computation burden. Such sparse correla-
tion matrix gets rid of part of correlation information by setting them to be zero.
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Hence it would not be positive-definite any more. We have to additionally shrink-
age this sparse matrix to be positive-definite for further generation of multivariate
normal vectors for large n, large J setting. Actually, it is pretty difficulty to get a
sparse and positive-definite estimated correlation matrix to accurately estimate the
population correlation matrix among genes. I tried a couple of ways and luckily find
out an appropriate method to estimate the true correlation matrix under large n,
large J setting.
Biologically, the correlation between any two markers is a decreasing function of
distance. In other word, two nearby markers would be more highly correlated than
two markers far apart. If two markers are far enough apart, we may ignore their
correlation by considering it to be zero. Setting those small correlations to be zeros,
we could restrict the correlation matrix to be a banded correlation matrix instead of
calculating every correlation entry. Such a sparse correlation matrix would improve
the efficiency for computation under high dimensions of markers. On one hand, there
is a storage format for sparse matrix that stores only the nonzero entries in column
order and hence avoid the storage of the zero entries. Thus it requires much less
memory to store the matrix. Moreover, the computation focuses on the numerical
values of the nonzero entries so as to reduce memory usage and avoid unnecessary nu-
merical operations. In this way, calculations based on sparse matrixes would provide
a significantly higher calculation efficiency. What's important, it is worthy to notice
that such banded sparse correlation matrix contains most of important correlation
entries without losing much information.
Here Figure 4.1 is a filled contour plot of sample correlation matrix under null
for 200 markers with the middle CNV size=30 for 10000 subjects and signal-to-noise
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Figure 4.1: This is the sample correlation matrix. Red values are high correlation;
the only legitimate correlations are located in the CNV. The rest is just noise.
ratio=2.
In this plot, the red square with high correlations focus on the middle CNV mark-
ers while noise smaller correlations are surrounding for the rest markers far apart.
Hence, it would be applicable and reasonable to ignore those noise and set those
correlations to be zeros. Instead, we could just give an estimate of middle banded
correlations for the neighboring markers as the estimate of a huge correlation matrix.
Including the whole red part, we would not lose much information and get the es-
timate more accurate and close to the true correlation. Define d to be the number
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of diagonals we calculate the pairwise correlation for the sparse matrix. d choosing
would effect the estimate of banded matrix. If using the true CNV size as d, the
estimated sparse correlation matrix would be the following plot Figure 4.2 and it
contains the whole central correlation of the sample correlation.
Figure 4.2: This is sparse matrix with d = 30 on both sides. It has the same central
banded correlation with the rest correlations equal to zero.
But if choosing a different d, the estimate would be very different. As seen in
Figure 4.3, the estimate loses a lot of important correlations when choosing half of
the true CNV size.
From the above demonstration, we must keep the central main correlation part to
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Figure 4.3: It is also a sparse estimate of correlation matrix with d = 15 on each
side. The important part of the correlation was chopped off.
estimate the true correlation matrix accurately. To keep the central high correlation
part of the sample correlation matrix, it would be best to choose d at least equal to
the CNV size for the sparse matrix. Otherwise, the estimation would lose a lot of
important correlation information and hence gets far away from the whole sample
correlation.
However, this sparse estimate would cause singular problems. Such sparse banded
correlation matrix might not be positive definite any more. A naive strategy to ob-
tain a positive definite estimator of covariance proposed by Rebonato (1999) runs
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as follows: take the sample covariance and decompose the covariance matrix into its
eigenvectors and eigenvalues, set the negative eigenvalues to 0 or (0 + ), and then
rebuild the covariance matrix. Higham (2001) uses an optimization procedure to find
the nearest correlation matrix that is positive semi-definite. Grubisic and Pietersz
(2003) have a geometric method they claim outperforms the Higham technique. In-
cidentally, some more recent twists on Rebonato's paper are Kercheval (2009) and
Rapisardo (2006) who build off of Rebonato with a geometric approach. They also
proposed several algorithms for computation to find its nearest correlation matrix.
However, such nearest positive definite covariance matrix could not be sparse and
thus it is computationally by far demanding for the very large dimensions commonly
encountered in genomics problems. Therefore, we aim to keep the estimate of corre-
lation matrix symmetric positive definite and sparse so that it will be a covariance
matrix of further multivariate normal distribution and meanwhile reduce the compu-
tation burden.
Special care should be taken in the construction of algorithms that create a large
symmetric sparse positive definite correlation matrix with the goal of reducing com-
putation time and memory usage. I present shrinkage strategy here to create such
sparse positive definite large-scale correlation matrix.
4.4.1 Introduction to shrinkage approach
A fundamental principle of statistical decision theory is that there exists an interior
optimum in the trade-off between bias and estimation error. We could shrinkage the
unbiased estimator full of estimation error towards a fixed target represented by the
biased estimator. Stein(1956) showed that shrinking sample means towards a con-
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stant would, under certain circumstances, improve accuracy. In the case of estimated
unbiased sample covariance matrix, those estimated coefficients that are extremely
high tend to contain a lot of positive error and therefore need to be pulled downwards
to compensate for that. Similarly, we compensate for the negative error that tends
to be embedded inside extremely low estimated coefficients by pulling them upwards.
We call this the shrinkage of the extremes towards the center to increase the accuracy.
Consider the well-known bias-variance decomposition of the mean square error
(MSE) for the sample covariance, i.e. MSE(S) = Bias(S)2 + V ar(S). We could
obtain an improved covariance estimator is variance reduction. Here we propose
shrinking or more general biased estimation as a means of variance reduction of
sample covariance matrix. If properly implemented, this shrinkage would clearly fix
the problem of the sample covariance matrix described above to be positive definite
and well-conditioned. A recent analytic result was proposed by Ledoit and Wolf
(2003) to construct an improved covariance estimator that is not only suitable for
small sample size n and large numbers of variables J but meanwhile is also com-
pletely inexpensive to compute [74]. They suggested the linear shrinkage approach to
combine both single-index covariance matrix estimator and sample covariance matrix
estimator in a weighted average. And they select the optimal shrinkage intensity
through explicitly minimizing a risk function for example the mean squared error
(MSE). It was based on the full sample covariance matrix. As illustrated earlier in
our cases, the sparse covariance matrix keeping the main high correlation part is rea-
sonable and accurate to get close to the full sample covariance matrix. Working on
such sparse covariance matrix, the key problem is that if we can figure out some simi-
lar shrinkage procedure to get it positive definite and keep it sparse in the meanwhile.
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Shrinkage here is applied to the correlations rather than the covariances. This has
two distinct advantages. First, the off-diagonal elements determining the shrinkage
intensity are all on the same scale. Second, the correlations derived from the result-
ing covariance estimator are independent of scale and location transformations of the
underlying data matrix. Working on the sparse matrix, we shrink the off-diagonal
entries of the sparse correlation matrix to zero gradually to reach the aim of posi-
tive definite matrix. We try the simple shrinkage on each entries of the sparse matrix.
In the following sections, I briefly review the general principles behind shrinkage
estimation of the sparse and positive definite correlation matrix and discuss an an-
alytic approach to determine the optimal shrinkage level and the number of sparse
diagonals.
4.4.2 Shrinkage estimation of sparse positive definite correlation matrix
As discussed above, we would get a symmetric sparse sample correlation matrix when
choosing an appropriate bandwidth. However, such sparse sample correlation matrix
could not be positive definite and thus it would have a lot of trouble when creating
the multivariate normal random vectors under the null. In this section I suggest us-
ing such sparse matrix obtained from the whole sample correlation matrix through a
transformation called shrinkage.
Define d to be the number of diagonals we calculate the pairwise correlation. First
of all, it is noteworthy that here the d has nothing to do with the bandwidth that we
need for kernel aggregation method. d is used to obtain a sparse correlation matrix to
estimate the actual correlation while bandwidth is to calculate a finite set of aggrega-
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tions {Tj} leading to significance testing based on the statistic T = maxj{Tj}. From
Figure 4.3, it is obvious that the choosing of d would effect the estimation of correla-
tion matrix. An appropriate d would have the sparse correlation matrix close to the
sample correlation and otherwise would get the estimation far away from the sample
correlation matrix. Thus, the sparse matrix with different d will produce different
estimation through shrinkage. I will talk more about the effect of d on estimation of
correlation matrix.
In order to obtain positive definite correlation matrix and keep it sparse as well,
we have to shrink the elements on the sparse matrix. As we know, the correlation
between any two markers is a decreasing function of distance. Two nearby markers
would be highly correlated while two markers far apart are less correlated. Thus, it
is reasonable to consider shrinking the correlations by distance. We could shrinkage
the correlations a little bit for highly correlated marker and meanwhile shrink the
correlations more and more as the markers get farther and farther. In some sense,
the sparse matrix would be much closer to be positive definite when the correlations
are decreasing gradually by distance.
Thus, I consider the exponential decline by distance. Let λ be the shrinkage
intensity and j be the number of markers away between two markers. For two markers
with j markers away, I shrinkage the correlation by (1 − λ)j. For any correlation
element, the new correlation element cor(i, i+ j)′ through shrinkage
cor(i, i+ j)′ = cor(i, i+ j) ∗ (1− λ)j, (4.10)
In other word, working on the sparse matrix with calculated pairwise sample corre-
lations for d diagonals, every element with sample correlation cor(i, i + j) between
marker i and marker i+ j would transfer into cor(i, i+ j) ∗ (1− λ)j. It makes some
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sense because the correlations of markers far apart would shrinkage a lot more than
the nearby markers. After such shrinkage step, we generate a sparse matrix with the
gradually decreasing correlations by distance. It will become positive definite when
we choose an appropriate shrinkage intensity λ.
4.4.3 Selection of the number of sparse diagonals and appropriate shrink-
age intensity
By the shrinkage procedure, we are allowed to construct an improved correlation es-
timator in a sparse and positive definite matrix that is not only suitable for large
sample size n and large numbers of variables J but at the same time is also com-
pletely inexpensive to compute. The larger the λ, the more shrinkage the sparse
correlation matrix gets. Thus, it will become positive definite more easily but mean-
while it changes the original correlations a lot and gets far away from the original
sparse sample correlation. A key question in this procedure is how to select an optimal
value for the shrinkage intensity. We wish to get a positive-definite correlation matrix
but shrinkage the correlations at minimum level. One common but computationally
intensive approach to estimate the minimizing λ is by using cross-validation. An-
other widely applied route to inferring λ views the shrinkage problem in an empirical
Bayes context. In our case here, the optimal shrinkage level could be determined an-
alytically. We can simply choosing minimum λ that guarantees the positive-definite
structure of the sparse correlation matrix without the need of specifying any underly-
ing distributions, and without requiring computationally expensive procedures such
as MCMC, the bootstrap, or cross-validation. In other word, the optimal shrinkage
level λ is determined by how sparse of the correlation matrix.
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Setting different number of sparse diagonals d, shrinkage intensity is obtained
by choosing minimum λ that guarantees the positive-definite structure of the sparse
correlation matrix. The relationship between d and λ is presented in Figure 4.4. It
appears that shrinkage intensity λ becomes smaller as the number of sparse diagonals
increases. It makes sense in some sense because the sparse correlation matrix gathers
more information when d is larger and then it is closer to the sample correlation which
is positive semi-definite and hence it does not require much shrinkage.
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Figure 4.4: Effect of the number of sparse diagonals on optimal shrinkage intensity.
True CNV size is set be 50 and total number of markers is 500.
As shown above, the number of diagonals d that we sparse the correlations also has
a lot of effects on the estimation of correlation matrix. Denote bw as the bandwidth
used for kernel aggregation method while d is the number of diagonals that create a
sparse correlation matrix. We always don't know either where the CNV is or the true
bandwidth of CNV. Basically we can choose any bandwidth for our kernel method.
It is shown that the larger bandwidth we choose for kernel aggregation method would
increase the power of detecting association between phenotype and intensities. After
choosing a bandwidth, the number of diagnose d would include different correlation
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information. Smaller d would get more sparse matrix while losing a lot more corre-
lation information. Furthermore, d choosing also effects type one error. The banded
sparse correlation matrix is more close to the whole sample correlation and includes
more information when d gets larger. By Theorem 2, when the estimated correlation
matrix gets much closer to the actual correlation matrix, the correlation approach
would preserve appropriate type one error. Therefore, we aim to select optimal d to
keep the correlation matrix sparse and also contain as much correlation information
and meanwhile preserve type one error as possible.
Figure 4.5 illustrates the relationship between d and type one error for different
bandwidth. For true CNV size of 50, we pick a set of bandwidths of 10,20,30,50,70,90
and 110, which include too small and too large bandwidth. Picking different number
of sparse diagonals for each bandwidth, the optimal shrinkage intensity λs are chosen
to be minimum to guarantee the positive definite structure of sparse correlation ma-
trix. From the plot, the effect of number of sparse diagonals on type one error are all
in the same trend for different bandwidths. Type one error goes down as increasing
d until the type one error gets stable. Hence, d needs to be larger than some choice
to preserve type one error. From simulation results, it seems to be safe to choose
d ≥ 3bw.
4.5 Simulation Results
I conducted simulation experiments in this section to evaluate the performance gain
that the correlation method provides and the cost in terms of its ability to detect
CNV-phenotype association. I first present the preservation of type one error of
correlation approach in different settings. Also, I compare the correlation method
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Figure 4.5: Effect of the number of sparse diagonals on preservation of type one error
when choosing different bandwidth for kernel aggregation method on normal signed
transformation. True CNV size is set be 50. The horizontal red line is for α = 0.05
in different settings to permutation method in the distribution of the the estimated
null distribution of the supremum statistic T = maxj{Tj} under no CNV-phenotype
association. Then, comparison of the computing times applying different approach
to conduct the kernel-based aggregation of marker-level association test will give us a
measure of the performance gain. For all these simulations, I follow the spike-in data
design fully described in Section 3.4. This procedure provides the simulation data
similar to the real data. For the simulations presented here, I use a sample size of
n = 1, 000 and an total markers J = 200 for large n, small J setting; use a sample
size of n = 50 and J = 500 assuming small n, large J; and n = 300 and J = 500 in
the case of large n, large J. Set signal-to-noise ratio of 2 for simulations.
4.5.1 Preservation of type one error
First of all, we are interested in the preservation of type one error of correlation
approach in each setting described above. Preservation of type one error is one
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important aspect to determine the performance of the method. In different settings,
we all consider a genomic region in which individuals may have a CNV. The purpose of
the analysis is to detect and locate such CNVs associated with a particular phenotype.
The null hypothesis for our association test may hold in one of two ways: (1, No
CNV) no individuals with CNVs are present in the sample, or (2, No association)
individuals with CNVs are present in the sample, but the CNV does not affect the
disease and thus dose not change the probability of developing the phenotype. The
effect of transformations of p-values and association direction would be similar. In
this section, I focus on the analysis for different transformations of p-values in signed
case. Simulation results are shown in tables and figures.
4.5.1.1 large n, small J setting
For large n, small J setting, I set n = 1000 and J = 200, which is exactly the same
setting as permutation approach. The results for the FWER analysis are summarized
in Table 4.1 for different transformations of p-values in signed direction of associations.
Table 4.1 perfectly demonstrates that correlation method under such setting is
guaranteed to preserves the correct type I error under both null hypothesis for differ-
ent transformations in signed directions of association under linear model assumption
between phenotype and genotype. This phenomenon is also illustrated graphically in
Figure 4.6. Obviously, the correlation method to estimate the whole sample correla-
tion is nice to apply since it preserves accurate type one error and p-values under the
null appear to be uniformly distributed.
4.5.1.2 small n, large J setting
For small n, large J setting, I set n = 50 and J = 500 for simulation. As details
described before, the rank of the estimated sample correlation does not depend on the
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Table 4.1: Preservation of Type I error for correlation method in large n, small J
setting for different transformations in signed direction of association with nominal
α = .05 in two possible settings for which the null hypothesis holds. The simulated
genomic region contained 200 markers, 30 of which were spanned by a CNV with
signal-to-noise ratio of 2. The CNV was present in either 0% or 50% of the 1000
samples, depending on the null hypothesis setting. A detailed description of the
simulation data is given in Section 3.4.
Signed Signed Signed
None Normal Log
No CNV 0.041 0.042 0.046
No Association 0.043 0.046 0.046
No CNV
None−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No CNV
Normal−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No CNV
Log−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
None−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
Normal−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
Log−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
Figure 4.6: Ability of correlation approach under different transformations in signed
directions of association for Large n, small J setting to maintain family-wise error
rate under the two null scenarios.
number of markers but on the sample size n. Applying singular value decomposition,
we simplify the correlation matrix and speed up the calculation. The results for the
FWER analysis are concluded in Table 4.2 for signed direction of associations with
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different transformations of p-values. And the distributions of p-values under two
kinds of H0 are shown as well in Figure 4.7.
Table 4.2: Preservation of Type I error for correlation method in small n, large
J setting for different transformations and directions of association with nominal
α = .05 in two possible settings for which the null hypothesis holds. The simulated
genomic region contained 500 markers, 30 of which were spanned by a CNV with
signal-to-noise ratio of 2. The CNV was present in either 0% or 50% of the 50
samples, depending on the null hypothesis setting. A detailed description of the
simulation data is given in Section 3.4.
Signed Signed Signed
None Normal Log
No CNV 0.049 0.049 0.048
No Association 0.046 0.047 0.048
From the table and figure, it is pretty good results in terms of the preservation of
type I error and p-values under two null are close to uniform distribution. Therefore,
although it is quite difficulty to estimate the whole sample correlation matrix using
tradition way under small n, large J setting, SVD approach provides a perfect al-
ternative to estimate the correlation matrix and conduct the kernel-base aggregation
of marker-level association test.
4.5.1.3 large n, large J setting
Similarly, under large n, large J setting, I take n = 300 and the total number of
markers J = 500. Applying shrinkage approach, it is necessary to select an optimal
number of sparse diagonals and an appropriate shrinkage intensity. As illustrated
in Section 4.4.3, the larger the number of sparse diagonal, the more information the
sparse correlation matrix includes and thus the more accurate estimate of correlation
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No CNV
None−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No CNV
Normal−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No CNV
Log−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
None−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
Normal−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
Log−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
Figure 4.7: Ability of SVD approach under small n, large J setting for different
transformations of p-values in signed association to maintain family-wise error rate
under the two null scenarios.
matrix, which requires less shrinkage. It is suggested to pick d ≥ 3bw from simula-
tions. Figure 4.5 shows that type one error tend to be stable when the number of
sparse diagonals is larger than one specific number. Therefore, as we do not know the
true CNV size, it will be better to pick a large d to preserve type I error and contain
the important correlation part while choosing a smaller d to keep it sparse. For the
simulation, I choose a bandwidth of 30 markers for kernel-based method and pick the
number of sparse diagonal d = 150 and minimum shrinkage intensity λ = 0.012 to
guarantee the sparse and positive-definite correlation matrix. The results of FWER
analysis are present in Table 4.3 and Figure 4.8.
Under large n, large J, a lot of approaches can not be applied and thus corre-
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Table 4.3: Preservation of Type I error for applying shrinkage approach on correlation
method for different transformations in signed association with nominal α = .05 in
two possible settings for which the null hypothesis holds. The simulated genomic
region contained 500 markers, 30 of which were spanned by a CNV with signal-to-
noise ratio of 2. The CNV was present in either 0% or 50% of the 300 samples,
depending on the null hypothesis setting.
Signed Signed Signed
None Normal Log
No CNV 0.052 0.047 0.038
No Association 0.062 0.059 0.053
No CNV
None−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No CNV
Normal−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No CNV
Log−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
None−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
Normal−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
No Association
Log−signed
p
0.0 0.2 0.4 0.6 0.8 1.0
Figure 4.8: Ability of shrinkage approach under different transformations in signed
association to maintain family-wise error rate under the two null scenarios.
lation matrix is complicated to estimate. In terms of preservation of type one error,
the shrinkage method seems to be a nice choice to estimate the correlation matrix
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under this setting when picking a proper d and shrinkage intensity λ.
4.5.2 Evaluating the estimated null distribution
It was clearly demonstrated that correlation approach in different settings success-
fully preserves type one error and thus they could be good to apply for estimation
of correlation matrix and conduct kernel-base aggregation of association tests. Then
we are interested in the estimation of the method under different settings. To see
the estimate of the method, it would be appropriate to compare the estimated null
distributions. I use the same settings as picked in last section for simulation. For each
setting, I compare the null distributions for each setting when applying permutation
method, the whole sample correlation estimate, SVD and shrinkage approach to the
kernel-based aggregation of marker-level association test.
From Figure 4.9, Figure 4.10, Figure 4.11, the null distributions stay very close
under different settings. Thus, the estimate and analysis results of kernel-based as-
sociation test would be similar for all those methods and we are capable to use those
approaches for each setting if not considering the performance. Besides, it is worth
to note that the shape of the null distributions are still similar to each other even if
we don't use the true CNV bandwidth.
4.5.3 Performance of correlation procedure
In the previous sections we showed that the estimated null distribution of correlation
method works well as the permutation method and they all successfully preserve type
one error. Thus, those correlation methods are good to use for any situation. Now, we
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Figure 4.9: Comparison of null distribution through permutation and three cor-
relation methods under large n, small J setting. The simulated genomic region
contained 200 markers, 30 of which were spanned by a CNV with signal-to-noise ra-
tio of 2. Population CNV frequency was presented in 50% of 1000 samples. Signed,
normal transformation with bandwidth bw = 20 was used for kernel-based method.
are more interested in evaluating the operating characteristics of correlation methods.
Unlike permutation method, the proposed correlation procedure involves the simu-
lation of multivariate normal variables rather than the genotype or phenotype data
and does not require repeated analysis of simulated data sets. The estimate of corre-
lation matrix involving the observed data is calculated only once, and the evaluation
of the null distribution given the estimated correlation matrix is trivial. Thus, the
proposed correlation approach provides a much more efficient procedure to generate
the null distribution than permutation approach. In this section we wish to assess
the reduction in computing time achieved by this procedure at no cost in terms of
false positive. We compare the performance of the correlation method to permutation
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Figure 4.10: Comparison of null distribution through permutation and three cor-
relation methods under small n, large J setting. The simulated genomic region
contained 500 markers, 30 of which were spanned by a CNV with signal-to-noise ra-
tio of 2. Population CNV frequency was presented in 50% of 50 samples. Signed,
normal transformation with bandwidth bw = 20 was used for kernel-based method.
approach in kernel-based aggregation of marker-level association test. We would like
to show the comparisons in terms of computation burdens and efficiency in low and
high dimensions.
4.5.3.1 large J setting
As illustrated, correlation-based approach has extended to the high dimensions in
efficient way. For large J setting, SVD approach is perfect for small sample size
and shrinkage is nice for large sample size. We set the total number of markers to
be 2000 for our simulation. When changing the sample size, the computation time
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Figure 4.11: Comparison of null distribution through permutation and three cor-
relation methods under large n, large J setting. The simulated genomic region
contained 500 markers, 30 of which were spanned by a CNV with signal-to-noise ra-
tio of 2. Population CNV frequency was presented in 50% of 300 samples. Signed,
normal transformation with bandwidth bw = 20 was used for kernel-based method.
comparisons are presented in Figure 4.12. First of all, the black line stays a lot higher
than the other three lines. Obviously, correlation approach performs much better than
the permutation approach in terms of the computation burden. Furthermore, when
the sample size gets larger, the gap between the black line ant the other three lines
becomes wider. It makes sense since the sample size effects a lot on the computation
time of permutation approach. Permutation approach would consume a lot more time
as the sample size gets larger. More clear comparisons of three correlation methods
under the same setting are shown in Figure 4.13. First, correlation method when
estimating the whole correlation matrix runs longer time than SVD and shrinkage
approach. It makes sense since the tradition correlation method estimates the whole
80
correlation matrix while SVD and shrinkage just provide estimate of part of the
correlation matrix. In terms of the computation time, SVD approach is much better
than shrinkage approach when the simple size is much smaller and meanwhile the
shrinkage approach is getting better when the sample size gets larger.
0 500 1000 1500
0
10
0
30
0
50
0
70
0
sample size
Co
ns
um
e 
tim
e
Permutation
Correlation
SVD
Shrinkage
Figure 4.12: Comparison of computation time versus sample size between correlation
methods and permutation approach. We set total number of markers to be 2000 and
the total number of samples changes from 10 to 1910 by 100. CNV size are 30 markers.
4.5.3.2 small J setting
In small J setting, we set the total number of markers to be 200. While changing the
sample size from 10 to 1910 by 100, the consuming time versus sample size is present
in Figure 4.14. We see that the black line is always higher than the blue and the gap
becomes larger and larger as the sample size gets larger. Thus, correlation approach
is also much better than permutation approach even under low dimension. Besides,
the consuming time for correlation method is more stable by sample size because the
estimate of correlation matrix depends on the number of markers not the sample size.
It is remarkable that he correlation method runs no more than one second here for
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Figure 4.13: Comparison of computation time versus sample size among three kinds
of correlation approaches. We set total number of markers to be 2000 and the total
number of samples changes from 10 to 1910 by 100. CNV size are 30 markers.
situation of 200 total number of markers. Note that here the correlation method is
giving the estimate of the whole correlation matrix.
This section demonstrates the performance of those methods and we would get
the conclusion that correlation approach is a better choice than the permutation ap-
proach in terms of the running time in both low and high dimensions. Moreover,
the SVD and shrinkage method are well applied for high dimension and consume less
time than the tradition correlation method that gives the estimate of whole correla-
tion matrix.
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Figure 4.14: Comparison of computation time versus sample size between permu-
tation approach and correlation method for low dimension. We set total number of
markers to be 200 and the total number of samples changes from 10 to 1910 by 100.
CNV size are 30 markers.
4.6 Gemcitabine study
In this section we apply the correlation approach to the real data and then compare
it to permutation approach. We begin by describing the design of a pharmacoge-
nomic study of gemcitabine, a commonly used treatment for pancreatic cancer. It is
the same data that is analyzed for application of permutation approach. Then we
analyze data applying the proposed correlation method on kernel-based aggregation
association test.
The gemcitabine study was carried out on the Human Variation Panel, a model
system consisting of cell lines derived from Caucasian, African-American and Han
Chinese-American subjects (Coriell Institute, Camden, NJ). Gemcitabine cytotoxic-
ity assays were performed at eight drug dosages (1000, 100, 10, 1, 0.1, 0.01, 0.001,
and 0.0001 uM) [60]. Estimation of the phenotype IC50 (the effective dose that kills
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50% of the cells) was then completed using a four parameter logistic model [61].
Marker intensity data for the cell lines was collected using the Illumina HumanHap
550K and HumanHap510S at the Genotyping Shared Resources at the Mayo Clinic in
Rochester, MN, which consists of a total of 1,055,048 markers [62,63]. Raw data were
normalized according to the procedure outlined in [64]. 172 cell lines (60 Caucasian,
53 African-American, 59 Han Chinese-American) had both gemcitabine cytotoxicity
measurements and genome-wide marker intensity data. To illustrate the application
of the kernel-based aggregation approach, we selected one chromosome (chromosome
3) from the genome-wide data. To control for the possibility of population stratifica-
tion, which can lead to spurious associations, we used the method developed by [65],
which uses a principal components analysis (PCA) to adjust for stratification. At
each marker, a linear regression model was fit with PCA-adjusted IC50 as the out-
come and intensity at that marker as the explanatory variable; these models produce
the marker-level tests.
We analyzed these data using the kernel-based approach described in Section 2.2
with a bandwidth of 50 markers and the log transformation. Instead of permutation
method on kernel, we demonstrate the correlation approach. As known, correlation
method depends on the estimation of correlation matrix and there are a couple of
choice for the different settings. For the real data involving with 70,542 markers for
172 cell lines, it is definitely a huge correlation matrix. It would be out of memory
to calculate the complete sample correlation matrix. But the small sample size in-
dicates that SVD will be a nice choice to estimate the correlation matrix. Also, we
could try the shrinkage method with appropriate shrinkage intensity and the number
of sparse diagonals. We pick d = 300 with minimum λ = 0.03 here. The results
are shown in Figure 4.15. Note the presence of a peak at 102.6 Mb. The horizontal
lines indicate the FWER-controlled, chromosome-wide significance threshold at the
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α = 0.1 level. These two cutoffs are close. It makes sense since the null distributions
are close to each other shown in Section 4.5.2. As the figure indicates, there are both
insufficient evidence in this study to establish a CNV association involving response
to gemcitabine (p = 0.158 for SVD and p = 0.204 for shrinkage) after controlling
the chromosome-wide FWER. Other choices of bandwidth and transformation would
produce qualitatively similar, although somewhat less significant, results. Compared
to the result of permutation in Figure 3.2 on the same real data with the same set-
ting, these cutoffs are close to the cutoff of permutation approach, which is around
2.5. Note that the cutoff of shrinkage method is a little bit higher than the SVD and
permutation approaches because shrinkage method losses correlation information to
some extent. Therefore, correlation method and permutation approach provide sim-
ilar results in terms of the performance. In terms of consuming time, SVD approach
and shrinkage method run much faster than permutation, which requires resampling
and runs a few hours. For this study, SVD just needs a couple of minutes to run the
result and shrinkage require approximately 15 mins for kernel-based study plus extra
time to get sparse correlation matrix and find out the optimal shrinkage intensity for
positive-definite correlation. Therefore, SVD approach would the best choice for such
data with much less sample size than the number of markers.
Copyright© Yinglei Li, 2014.
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Figure 4.15: Analysis of the gemcitabine data (Chromosome 3) using the proposed
correlation method. The kernel aggregations Tj are plotted against chromosomal
position. The red line indicates the cutoff of SVD approach and the blue line shows
the cutoff of shrinkage approach for chromosome-wide FWER significance at the
α = .1 level.
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Chapter 5 Summary and Discussion
This dissertation is devoted to the analysis of CNV-phenotype association testing.
Specially, we have reviewed the traditional and popular variant-level testing, which
do "CNV calling" first for each individual and then carry out association test of
whether individual with a CNV differ from individual without a CNV with respect
to some phenotype. We focus on the marker-level testing, where we do the asso-
ciation test for every single marker first then determine CNV-phenotype associated
regions by pooling test results across neighboring markers. Here in the dissertation
we develop a kernel-based aggregation method for marker-level association test. Con-
ducting such an association test, I propose a permutation approach and correlation
method to estimate the null distribution of the test statistic.
In summary, permutation tests provide a robust and powerful method of testing
statistical hypotheses that is intuitive and easy in practice. More importantly, it
provides an accurate FWER control and does not rely on any model assumptions.
However, the permutation approach has its own limitations. First, this approach is
valid and widely used only under very mild conditions complete exchangeability
under null hypothesis as described above. Thus it may not be applicable when there
are covariates or nuisance parameters [57]. Especially, the permutation distribution
may not be appropriate when the analysis involves covariates that are correlated
with both genotype and phenotype. Moreover, it becomes computationally demand-
ing since the analysis needs to be repeated for each permuted dataset while creating
the null distribution of test statistic. The kernel aggregation itself is very fast, but
the need to carry out ≈ 1, 000 permutation tests for each marker may be highly com-
putationally intensive, depending on the complexity of the marker-level test. Thus,
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the computing problem is critical for permutation approach.
The proposed correlation method is demonstrated to offer large improvements in
speed. First it does not involve repeated analyses of simulated datasets and is thus
provides a substantial gain in speed with only a negligible loss in accuracy. Second,
it does not require complete exchangeability and is thus widely applicable. Thus,
correlation method appears to be a better choice than permutation in terms of the
computation time. Moreover, extending this method to high dimension, we develop
SVD and shrinkage method, which are presented to also preserve type one error and
require much less running time.
The simulation studies of Section 3.4 address a limited-scale version of a larger
question: how do marker-level test aggregation and variant-level testing compare for
chromosome-wide and genome-wide analysis? This is an important question and de-
serves further study. In general, multiplicity is a thorny issue for CNV analyses, as
the true location of CNVs are unknown and can overlap in a number of complicated
ways. The issue of how many tests to carry out and adjust for is a challenging ques-
tion for variant-level testing and a considerable practical difficulty in analysis. In
contrast, aggregation of marker-level results avoids this issue altogether. We have
shown that the proposed approach is both powerful at detecting CNV associations
and rigorously controls the FWER at a genome-wide level  two rather appealing
properties. However, future work applying the proposed method to larger, more com-
plex settings is necessary.
In this dissertation, I have focused on continuous phenotype, with association test-
ing performed using linear regression. The kernel-based aggregation method itself,
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however, requires only p-values and can be extended to a more complicated marker-
level tests assuming nonlinear, mixed-effects, or mixture models between intensity
and phenotype. Furthermore, our simulations involve a very simple genetic scenario:
a small segment of DNA in which a single CNV is either present or absent. It is im-
portant and valuable to understand the properties of marker-level approach in these
simple cases. However, future research involving more complicated scenarios is also
needed.
Copyright© Yinglei Li, 2014.
89
Appendices
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A.Proof of Theorem 1
Proof of Theorem 1. Let P denote the set of all possible permutations of {yi}, F0
the CDF of Tmax over P , and F−10 its generalized inverse. Also, let φ(X,y) = 1 if
Tmax(X,y) > F
−1
0 (1− α) and 0 otherwise.
Now, note that under the null hypothesis that xi and yi are independent,
P (X,y) =
∏
i
P (xi, yi)
=
∏
i
P (xi)P (yi)
= P (X,y∗)
for all y∗ ∈ P . Thus, E0φ(X,y∗) is a constant for all y∗ and
E0 {φ(X,y)} = 1
n!
∑
y∗∈P
E0φ(X,y∗)
= E0
1
n!
∑
y∗∈P
φ(X,y∗)
≤ α,
where the term inside the expectation in the second line is less than or equal to α for
all X and y by the construction of the test.
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B. Proof of Theorem 2
Proof of Theorem 2. Assume simple linear regression y = β0 + β1jxj +  between
intensities xj and y for subjects is, where  has a normal distribution with mean
0 and standard deviation σ. By standardization, we define xij − x¯j = x′ijsdxij and
yi − y¯ = y′isdyi , where we denote standardized x′ij and y′i. Under the simple linear
regression model, we have the z-statistics under H0:
Zj =
βˆ1j − 0
s.e.
=
∑
(xij−x¯j)(yi−y¯)∑
(xij−x¯j)2
σˆ
√
1/
∑
(xij − x¯j)2
=
∑
sdxijx
′
ijsdyiy
′
i
σˆ(n− 1)sd2xij
√
(n− 1)sd2xij
=
∑
x′ijy
′
i√
(n− 1) ,
where
∑
(xij − x¯j)2 = (n− 1)sd2xij and also σˆ = sdyi .
Now, correlation between two p-values is equivalent to the correlation between the two
corresponding z statistics. Therefore, correlation between z statistics of two markers
is simplified by (4.2),
cor(zj, zk) = cor(
∑
x′ijy
′
i√
(n− 1) ,
∑
x′iky
′
i√
(n− 1))
= cor(
∑
x′ijy
′
i,
∑
x′iky
′
i)
= cor(
∑
x′ij,
∑
x′ik),
since under the null hypothesis that xij and yi are independent.
By (4.2) again,
cor(zj, zk) = cor(
∑
x′ij,
∑
x′ik)
= cor(xj,xk)
Thus,correlation structure among p-values under H0 exactly equals the correlation
matrix of the intensities among markers.
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C. R code for Permutation Method
####kernel-based association test
## Input: X (matrix of intensity values)
## y (vector of phenotypes)
## FUN (If P and S are not supplied, must supply FUN
## a function which carries out the marker-level testing;
## must return vector of p-values or a list with components
## 'p' and 's' if signed aggregation is to be carried out)
## bw (bandwidth)
## pos (position of markers on chromosome)
## trans (transformation)
## test (if TRUE, calculates F0)
## N (Number of permutations)
## ... (arguments passed to FUN)
## Output: T (test statistic)
## p (p-value of t)
## Tmax
kbag <- function(obj, ...) UseMethod("kbag")
kbag.permTest <- function(obj, ...)
{
if (attr(obj, "signed")) kbag.numeric(p=obj$p, s=obj$s, P=obj$P, S=obj$S, ...)
else kbag.numeric(p=obj$p, P=obj$P, ...)
}
kbag.function <- function(FUN, X, y, test=TRUE, N=1000, showProgressBar=TRUE, ...)
{
## Evaluate FUN
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FUN.args <- as.list(formals(FUN))
dots <- list(...)
matched <- names(dots)[names(dots) %in% names(FUN.args)]
if (length(matched)) FUN.args[matched] <- dots[matched]
FUN.args[[1]] <- X
FUN.args[[2]] <- y
fun.val <- do.call(FUN, FUN.args)
signed <- FALSE
s <- S <- P <- NULL
if (is.numeric(fun.val)) {
p <- fun.val
} else if (is.list(fun.val)) {
p <- fun.val$p
if ("s" %in% names(fun.val)) {
s <- fun.val$s
signed <- TRUE
}
} else stop("FUN returns unrecognized format")
## Calculate P, S
if (test) {
P <- matrix(NA, nrow=N, ncol=ncol(X))
if (signed) S <- P
for (i in 1:N) {
FUN.args[[2]] <- sample(y)
res <- do.call(FUN, FUN.args)
if (!signed) P[i,] <- res else {
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P[i,] <- res$p
S[i,] <- res$s
}
if (showProgressBar) displayProgressBar(i,N)
}
}
if (signed) kbag.numeric(p, s, P=P, S=S, test=test, ...) else kbag.numeric(p, P=P, test=test, ...)
}
kbag.numeric <- function(p, s, bw, X, N=1000, P, S, pos=1:length(p), trans=c("log","normal","none"), test=TRUE, ...)
{
## Aggregate
signed <- if (missing(s)) FALSE else TRUE
if (signed & missing(trans)) trans <- "normal"
trans <- match.arg(trans)
if (missing(bw)) stop("You must supply a bandwidth")
if (signed) {
if (trans=="none") x <- s*(1-p)
if (trans=="normal") x <- qnorm((1+s*(1-p))/2)
if (trans=="log") x <- -s*log(p)
} else {
if (trans=="none") x <- 1-p
if (trans=="normal") x <- qnorm(1-p)
if (trans=="log") x <- -log(p)
}
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out <- .C("KBAGN", double(length(p)-2*(bw-1)), integer(length(p)-2*(bw-1)), integer(1), as.double(x),as.double(pos),as.integer(length(p)),as.integer(bw))
T <- out[[1]]
names(T) <- pos[out[[2]]]
Tmax <- if (signed) max(abs(T)) else max(T)
## Calculate F0, test
#########This part will be different when applying different approaches to get F0#################
if (test) {
if (missing(P)) {
if (missing(X)) stop("If test=TRUE, must supply either X (matrix of intensities) or P (matrix of draws from null); see documentation")
Sigma <- cor(X)
require(mvtnorm)
Z <- rmvnorm(N, sigma=Sigma, method="svd")
if (signed) {
P <- 2*pnorm(-abs(Z))
S <- sign(Z)
} else P <- 1-pchisq(Z^2,1)
}
F0 <- if (signed) getF0(P, S, bw=bw, pos=pos, trans=trans) else getF0(P, bw=bw, pos=pos, trans=trans)
p.value <- 1-F0(Tmax)
} else {
p.value <- NULL
F0 <- NULL
}
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## Return
structure(list(Tmax=Tmax, p=p.value, F0=F0, T=T, signed=signed, bw=bw, trans=trans), class="kbag")
}
## Obtains null distribution for Tmax using permutation testing
getF0 <- function(P, S, bw, pos, trans)
{
N <- nrow(P)
x <- numeric(N)
if (missing(S)) for (i in 1:N) x[i] <- kbag(P[i,], bw=bw, pos=pos, trans=trans, test=FALSE)$Tmax
else for (i in 1:N) x[i] <- kbag(P[i,], S[i,], bw=bw, pos=pos, trans=trans, test=FALSE)$Tmax
ecdf(x)
}
###Simulation data
## n = number of subjects
## g = frequency of CNV
## m = number of SNPs / CNV
## snr = signal-to-noise ratio
## J = # of markers
## pen = penetrance
## standardized = standardize X and y?
genData <- function(n, g, m, snr=0.8, delta=1, J=200, pen, noise.type=c("spike","model"), standardized=FALSE)
{
noise.type <- match.arg(noise.type)
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if (m%%2!=0) stop("m must be even")
## Generate y, z
if (missing(pen))
{
z <- rbinom(n,1,g)
y <- genY(n=n,delta=delta,z=z)
}
else
{
if (n%%2!=0) stop("n must be even in a case-control study")
y <- c(rep(0,n/2),rep(1,n/2))
p <- numeric(n)
p[y==1] <- g*pen[2]/(g*pen[2]+(1-g)*pen[1])
p[y==0] <- g*(1-pen[2])/(g*(1-pen[2])+(1-g)*(1-pen[1]))
z <- rbinom(n,1,p)
}
## Generate X
X <- Z <- matrix(0,nrow=n,ncol=J)
j <- c(-(J/2):-1,1:(J/2))
Z[z==1,abs(j) <= m/2] <- snr
if (noise.type=="spike") {
if (is.null(attr(R,"sd"))) {
sd.r <- sd(as.numeric(R))
} else sd.r <- attr(R,"sd")
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a <- sample(1:(ncol(R)-J),1)
markers <- sample(1:ncol(R),J)
noise <- as.numeric(R[sample(1:nrow(R),n,replace=TRUE),markers]/sd.r)
} else {
E <- matrix(rbinom(J*n,size=1,prob=.3),ncol=J)
R1 <- matrix(rdex(J*n,0,1),ncol=J)
R2 <- matrix(rnorm(J*n,0,1))
noise <- E*R1+(1-E)*R2
}
X <- Z + noise
val <- list(y=y,X=X,Z=Z,z=z)
if (noise.type=="spike") {
start <- sample(1:length(pos), 1)
val$pos <- pos[start:(start+J-1)]
}
if (standardized) {
val$X <- standardizeX(val$X)
val$y <- standardizeY(val$y)
}
val
}
genY <- function(n,delta,z,pen)
{
return(rnorm(n,mean=delta*z))
##yy <- rbinom(n,size=1,prob=pen[z+1])
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##return(list(y=y,yy=yy))
}
####standardize data
standardizeX <- function(X)
{
n <- nrow(X)
center <- colMeans(X)
X.c <- sweep(X,2,center)
scale <- sqrt(apply(X.c,2,crossprod)/(n-1))
sweep(X.c,2,scale,"/")
}
standardizeY <- function(y){(y-mean(y))/sd(y)}
#####linear regression between intensity and phenotype
mlt <- function(XX, yy, type=c("continuous", "discrete"), signed=TRUE, return.line=FALSE, standardized=FALSE)
{
type <- match.arg(type)
if (type=="continuous") {
n <- length(yy)
if (standardized) {
b <- crossprod(XX,yy)/n
R <- yy - sweep(XX,2,b,"*")
t. <- b/(sqrt(apply(R,2,crossprod)/(n-2)/n))
} else {
meany <- mean(yy)
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y <- yy - meany
meanx <- apply(XX,2,mean)
X <- t(t(XX) - meanx)
Xy <- crossprod(X,y)
XX <- apply(X,2,crossprod)
b <- as.numeric(Xy/XX)
if (return.line) a <- meany-b*meanx
R <- y - t(t(X)*b)
t. <- b/(sqrt(apply(R,2,crossprod)/(n-2)/XX))
}
}
if (type=="discrete") {
n <- length(yy)
fit <- lm(XX~yy)
MSE <- apply(fit$residuals,2,crossprod)/(n-2)
SXX <- crossprod(yy-mean(yy))
SE <- sqrt(MSE/SXX)
b <- fit$coef[2,]
if (return.line) a <- fit$coef[1,]
t. <- b/SE
}
p <- 2*pt(-abs(t.),n-2)
if (!return.line & !signed) val <- p else val <- list(p=p)
if (return.line) val <- append(val,list(b=b, a=a))
if (signed) val <- append(val,list(s=sign(t.)))
val
}
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####plot kbag result####
plot.kbag <- function(x,F0,alpha=.05,pch=19,cex=.1,ylim,...)
{
if (!missing(F0)) x$F0 <- F0
T <- x$T
Position <- as.numeric(names(x$T))
if (is.null(x$F0)) {
if (missing(ylim)) ylim <- range(T)
plot(Position,T,pch=pch,cex=cex,ylim=ylim,...)
} else {
cutoff <- quantile(x$F0,1-alpha)
if (x$signed) {
ylim <- range(c(T,-cutoff,cutoff))
plot(Position,T,pch=pch,cex=cex,ylim=ylim,...)
abline(h=cutoff,col="red",lwd=2)
abline(h=-cutoff,col="red",lwd=2)
} else {
ylim <- range(c(T,cutoff))
plot(Position,T,pch=pch,cex=cex,ylim=ylim,...)
abline(h=cutoff,col="red",lwd=2)
}
}
}
## Standardized
Data <- genData(n=300, g=0.5, m=50,delta=0, standardized=TRUE)
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mlt(Data$X, Data$y)$p[1:10] ## Same as below
mlt(Data$X, Data$y, standardized=TRUE)$p[1:10] ## Same as above
fit <- kbag(mlt, Data$X, Data$y, bw=30, standardized=TRUE)
plot(fit)
###Demo
###permutation-based###
Data <- genData(n=300, g=0.5, m=50,delta=0)
fit <- kbag(mlt, Data$X, Data$y, bw=30, test=FALSE)
fit <- kbag(mlt, Data$X, Data$y, bw=30)
plot(fit)
## P
Data <- genData(n=300, g=0.5, m=50, delta=0, standardized=TRUE)
P <- S <- matrix(NA, nrow=1000, ncol=200)
for (i in 1:1000) {
res <- mlt(Data$X, sample(Data$y), standardized=TRUE)
P[i,] <- res$p
S[i,] <- res$s
displayProgressBar(i, 1000)
}
res <- mlt(Data$X, Data$y, standardized=TRUE)
fit <- kbag(res$p, res$s, P=P, S=S, bw=30)
plot(fit)
fit <- kbag(res$p, res$s, P=P, S=S, bw=50, trans="none")
plot(fit)
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D. R code for Correlation Method
#####Basic correlation method to get the whole sample correlation matrix#####
## Single example -- "manual"
Data <- genData(n=300, g=0.5, m=50, delta=0, snr=20)
res <- mlt(Data$X, Data$y)
Sigma <- cor(Data$X)
Z <- rmvnorm(1000, sigma=Sigma, method="svd")
P <- 2*pnorm(-abs(Z))
S <- sign(Z)
fit <- kbag(res$p, res$s, P=P, S=S, bw=30)
plot(fit)
## Single example -- "automatic"
Data <- genData(n=300, g=0.5, m=50, delta=0, snr=20)
res <- mlt(Data$X, Data$y)
fit <- kbag(res$p, res$s, bw=30, X=Data$X)
plot(fit)
## Simulation
N <- 500
p <- numeric(N)
for (i in 1:N) {
Data <- genData(n=300, g=0.5, m=50, delta=0, snr=20)
res <- mlt(Data$X, Data$y)
fit <- kbag(res$p, res$s, bw=30, X=Data$X)
p[i] <- fit$p
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displayProgressBar(i, N)
}
hist(p, col="gray", breaks=c(0,1,.01), border="white")
#####shrinkage approach
diags <- function(XX, d) {
X <- standardizeX(XX)
n <- nrow(X)
p <- ncol(X)
B <- matrix(0, p, d)
for (i in 1:p) {
for (j in 1:d) {
if (i+j > p) break
B[i,j] <- crossprod(X[,i], X[,(i+j)])/n
}
}
B
}
smoothB1 <- function(B,alpha) {
n <- nrow(B)
p <- ncol(B)
BB <- matrix(0, n, p)
for (i in 1:n) {
for (j in 1:p) {
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BB[i,j] <- B[i,j]*(1-alpha)^j
}
}
BB
}
multiz3h <- function(n=1000,XX, d,alpha) {
t<-ncol(XX)
require(Matrix)
require(psych)
B <- diags(XX, d)
BB<-smoothB1(B,alpha=alpha)
S <- bandSparse(nrow(BB), k=0:ncol(BB), diag=cbind(rep(1, nrow(BB)),BB), symmetric=TRUE)
cholS <- chol(S)
z<- array(rnorm(t*n),c(n,t)) %*% cholS ##see str(mvsamples)
z<-as.matrix(z)
return(z) ####give n*t matrix
}
###find the best shrinkage intensity
aa<-seq(0.1,0.15,0.01)
l<-length(aa)
N=500
s<-array(data<-0,dim=c(l,N),dimnames=list(aa,1:N))
for (i in 1: l)
{
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for (j in 1:N)
{
Data <- genData(n=50,g=0.5,m=100,delta=0,snr=2,J=500)
B <- diags(Data$X, 10)
BB<-smoothB1(B,alpha=aa[i]) ###alpha=0.03 seems okay
S <- bandSparse(nrow(BB), k=0:ncol(BB), diag=cbind(rep(1, nrow(BB)),BB), symmetric=TRUE)
ss<-as.matrix(S)
s[i,j]<-sum(eigen(ss)$values < 0)
}
displayProgressBar(i, l)
}
S<-apply(s,1,sum)
#####Getting F0 and only change one part of kbag function
Z<-multiz3h(n=N,X,d,alpha)
###Or:
Data <- genData(n=300,g=0,m=30,delta=0,snr=2,J=500)
res <- mlt(Data$X, Data$y)
fit <- kbag2(res$p, bw=30,d=150,alpha=0.012, X=Data$X, trans="none")
#####Applying SVD on kbag function
## Single example -- "manual"
Data <- genData(n=50, g=0.5, m=30, delta=0, snr=2,standardized=TRUE, J=500)
nn <- N<-1000
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X<-Data$X
n=dim(X)[1]
X <- standardizeX(X)
ZZ <- matrix(rnorm((n-1)*nn), nn, n-1)
SVD <- svd(X, nu=0, nv=n-1)
A <- sweep(SVD$v, 2, SVD$d[1:(n-1)], "*")/sqrt(n)
Z <- tcrossprod(ZZ, A)
P <- 2*pnorm(-abs(Z))
S <- sign(Z)
fit <- kbag(res$p, res$s, P=P, S=S, bw=30)
##Or
fit <- kbag(res$p, res$s, bw=30, X=Data$X)
plot(fit)
Copyright© Yinglei Li, 2014.
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